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Abstract
The adaptation and evaluation of contemporary data mining methods to chemi-
cal and biological problems is one of major areas of research in chemoinformatics.
Currently, large databases containing millions of small organic compounds are
publicly available, and the need for advanced methods to analyze these data in-
creases. Most methods used in chemoinformatics, e.g. quantitative structure-
activity relationship (QSAR) modeling, decision trees and similarity searching,
depend on the availability of large high-quality training data sets. However, in
biological settings, the availability of these training sets is rather limited. This is
especially true for early stages of drug discovery projects where typically only few
active molecules are available. The ability of chemoinformatic methods to gener-
alize from small training sets and accurately predict compound properties such as
activity, ADME or toxicity is thus crucially important. Additionally, biological
data such as results from high-throughput screening (HTS) campaigns is heavily
biased towards inactive compounds. This bias presents an additional challenge
for the adaptation of data mining methods and distinguishes chemoinformatics
data from the standard benchmark scenarios in the data mining community.
Even if a highly accurate classifier would be available, it is still necessary to
evaluate the predictions experimentally. These experiments are both costly and
time-consuming and the need to optimize resources has driven the development of
integrated screening protocols which try to minimize experimental efforts but still
reaching high hit rates of active compounds. This integration, termed “sequential
screening” benefits from the complementary nature of experimental HTS and
computational virtual screening (VS) methods.
In this thesis, a current data mining framework based on class-specific nomi-
nal combinations of attributes (emerging patterns) is adapted to chemoinformatic
problems and thoroughly evaluated. Combining emerging pattern methodology
and the well-known notion of chemical descriptors, emerging chemical patterns
(ECP) are defined as class-specific descriptor value range combinations. Each
pattern can be thought of as a region in chemical space which is dominated by
compounds from one class only. Based on chemical patterns, several experiments
are presented which evaluate the performance of pattern-based knowledge min-
ing, property prediction, compound ranking and sequential screening. ECP-based
classification is implemented and evaluated on four activity classes for the pre-
diction of compound potency levels. Compared to decision trees and a Bayesian
binary QSAR method, ECP-based classification produces high accuracy in pos-
itive and negative classes even on the basis of very small training set, a result
especially valuable to chemoinformatic problems.
The simple nature of ECPs as class-specific descriptor value range combina-
tions makes them easily interpretable. This is used to related ECPs to changes
in the interaction network of protein-ligand complexes when the binding confor-
mation is replaced by a computer-modeled conformation in a knowledge mining
experiment. ECPs capture well-known energetic differences between binding and
energy-minimized conformations and additionally present new insight into these
differences on a class level analysis.
Finally, the integration of ECPs and HTS is evaluated in simulated lead-
optimization and sequential screening experiments. The high accuracy on very
small training sets is exploited to design an iterative simulated lead optimization
experiment based on experimental evaluation of randomly selected small training
sets. In each iteration, all compounds predicted to be weakly active are removed
and the remaining compound set is enriched with highly potent compounds. On
this basis, a simulated sequential screening experiment shows that ECP-based
ranking recovers 19% of available compounds while reducing the “experimental”
effort to 0.2%. These findings illustrate the potential of sequential screening pro-
tocols and hopefully increase the popularity of this relatively new methodology.
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1 Introduction
Machine learning algorithms are widely used in chemoinformatics for the predic-
tion of compound properties, including physicochemical properties like logP or
biological activity. Adapted algorithms include partitioning methods (Rusinko
et al., 1999; Stahura and Bajorath, 2003), clustering algorithms (Feher and
Schmidt, 2003; Tamura et al., 2002), neural networks (Keseru¨ et al., 2000; Sad-
owski, 2000), Bayesian models (Labute, 1999; Vogt et al., 2007), decision trees
(Rusinko et al., 1999; Stockfisch, 2003) and kernel based methods (Geppert et al.,
2008; Harper et al., 2001; Jorissen and Gilson, 2005).
The recent increase in available data for pharmaceutical or biological purposes
drives the need for efficient data mining tools to explore, manipulate and analyze
these data sets. Commercial data sources, e.g. the MDL drug data report data-
base1 or the Wombat database (Olah et al., 2004) and public efforts such as Pub-
Chem2 or the ZINC database (Irwin and Shoichet, 2005) collect large amounts
of data about organic compounds. PubChem now contains 40 million records
about 19 million unique structures including information from more than 1000
biological assays, and the ZINC database contains ∼8 million compounds in total
and ∼5 million drug-like molecules. Libraries like the MDDR or the Wombat
library have also introduced a qualitative advancement in their collection of veri-
fied information about compounds from sources like patent information or journal
publications. However, the fraction of experimentally tested compounds remains
extremely small compared to the estimated number of possible organic molecules
(Kirkpatrick and Ellis (2004) cite an estimate of more than 1060 potential small
organic molecules) even though high-throughput screening (HTS) technology has
made dramatic advances in the last years and enabled the automatic screening
of millions of compounds for desired properties in a short time. Faced with this
large amount of data, the application of contemporary data mining algorithms is
becoming one of the fundamental topics in chemoinformatic research. Tradition-
ally, chemoinformatics has borrowed algorithms such as clustering or partitioning
1MDL Drug Data Report from MDL Information Systems, San Leandro, CA, USA. Available
at http://www.mdl.com/products/knowledge/drug_data_report/
2http://pubchem.ncbi.nlm.nih.gov
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2from the data mining community and invented new approaches such as similarity
searching based on molecular fingerprints. Many of these algorithms are used to
select small subsets from large compound libraries which have a high probability
to show desired properties, e.g. activity against a target.
This thesis presents the adaptation of a recently developed pattern mining
framework to chemoinformatic problems. It adapts the emerging pattern (EP)
mining algorithms to molecular data by using discretized molecular descriptors
as attributes. EP mining finds class-specific combinations of attributes with high
frequency in a home class but low occurence in a background data set. In this
way, class-specific knowledge about molecules will be encoded as combinations of
descriptor value ranges. Each combination can be thought of as a class-specific
chemical descriptor space dominated by compounds from one class only. Appli-
cations of the EP mining framework include molecular classification, ranking and
knowledge mining on conformational data sets.
Besides introducing a new data mining method into the chemoinformatics re-
search area, special attention is paid to possible efficient integration of computa-
tional and experimental methods. Both research areas, computational chemistry
or chemoinformatics and the experimentally HTS technology, have made dramatic
advances in the last years. It is now possible to automatically screen millions of
compounds in reasonable time. However, an undirected brute-force search is very
likely to waste valuable resources by inspecting many unpromising compounds.
Computational methods are in a sense orthogonal to experimental methods. With
computational means, it is possible to screen even larger compound libraries in
short time and to access compounds which are not available for experimental
testing. Traditionally, both methods are used exclusively (experimental testing is
of course also used to validate virtual screening (VS) results). It has been pro-
posed that an integration of computational and experimental efforts leads to an
improvement in screening methodology by reducing the experimental effort while
achieving significant hit rates of active compounds (Bajorath, 2002). Although
proposed several years ago, the integrated “sequential screening” paradigm is far
from being implemented in standard drug discovery projects and lacks evalua-
tion studies. The second part of this thesis is concerned with two “experiments”
exploring the potential of sequential screening.
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1.1 Related work
The application of data mining algorithms to search for hidden knowledge in the
form of combinations of features has a long history in chemoinformatics and re-
lated fields such as bioinformatics. Given the long tradition of string algorithms
in bioinformatics, it is not surprising that many prominent examples are actu-
ally string mining methods. Frequent substring mining approaches are used to
find repetitive structures such as common subsequences in proteins. These algo-
rithms can be efficiently implemented using suffix trees (Gusfield, 1997). Recently,
Fischer et al. (2006) have introduced linear-time algorithms to find emerging sub-
strings, i.e. substrings frequent in one set but rare in another set of strings.
In chemoinformatics, pattern mining is used in a more general sense than the
common data mining concept of frequent pattern mining. Most applications of
pattern mining algorithms focus on the discovery of frequent or common sub-
structures of sets of molecules. Nicolaou and Pattichis (2006) review the most
important algorithms for molecular substructure mining. All these algorithms
compute frequent substructures for a set of molecules. However, they do not take
class information, e.g. activity, into account and thus cannot be used to compute
common substructures which are specific for sets of active compounds in contrast
to a background database. Ting and Bailey (2006) present an application of a
hypergraph based algorithm which is also used to compute emerging patterns to
compute class-specific emerging subgraph patterns. Common to all graph-mining
algorithms is that they are computationally expensive and only applicable for
small data sets.
Related to common substructure mining, fragment based approaches are some-
times used to find common fragments in sets of compounds. In contrast to
substructure mining, fragment-based methods typically use a set of predefined
fragments to screen a database of molecules. A simple example of a fragment-
based approach is the MACCS structural keys fingerprint which assigns to each
molecule a bit vector accounting for presence or absence of 166 structural frag-
ments. Substructure mining and most fragment-based approaches do not consider
combinations of substructures, but are only concerned with the identification of
frequent single structural entities. Fragment-based methods are sometimes used
to find combinations of class-specific fragments, but they usually use only small
combinations of fragments (Lounkine et al., 2008). Sometimes, statistical sam-
pling (Lameijer et al., 2006) is used to cut down computation time and escape the
problem of exponential growth of possible fragment combinations. Both methods
1.2. RESEARCH TOPICS 4
further restrict the number of fragments by breaking molecules into chemically
reasonable parts of ring systems, linkers and side chains. Lameijer et al. (2006)
then count co-occurrence of fragments in a stochastic experiment without includ-
ing a background database. The experiments described by Lounkine et al. (2008)
are closely related to emerging pattern mining since they show how formal con-
cept analysis can be used to interactively construct queries on sets of fragments
computed from compounds with associated selectivity data. Initial evaluations
have shown that typical fragment combinations consist of only a handful of frag-
ments and thus the search is restricted to use only four fragments at most. It is
shown that these combinations of fragments are highly specific for activity classes
and thus using a data mining approach to compute class-specific descriptor value
combinations seems a promising and reasonable idea.
In a way, similarity searching algorithms like DynaMAD (Eckert and Bajorath,
2006) and CA-DynaMAD (Vogt and Bajorath, 2008) are similar to emerging
pattern mining. CA-DynaMAD heuristically computes class-specific combinations
of descriptor value ranges which are then used for assessing the probability of
test compounds for being active against the same target as the molecules in the
training set. Both algorithms first rank class-specific descriptor value ranges3
based on the number of (inactive) database compounds matched by this value
range. For classification, they iteratively eliminate database compounds which do
not match the top-ranking descriptor value ranges, traversing the descriptors in
descending order. The implementation differs, but both methods result in a small
set of potentially active compounds and a corresponding descriptor value range
set which includes all descriptors used in the iterations. This descriptor set can be
interpreted as a class-specific chemical reference space. However, these algorithms
do not use data mining methods to explore possible combinations of descriptors,
but heuristically select the next descriptors on the basis of their score.
1.2 Research topics
This thesis investigates how current pattern mining methods can be used in
drug discovery research. More specifically, it is concerned with the application
of pattern mining technologies computing class-specific combinations of discrete
attributes to chemical knowledge mining, classification and ranking. The adapta-
tion of data mining algorithms is also an interesting experiment from a computer
3The min. and max. values for a descriptor in the active training set are used as the class-
specific descriptor value range (min,max).
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science point of view. Data sets such as results from biological screening cam-
paigns are different from the standard benchmark sets used in the data mining
community. First, most screening data sets contain intrinsic errors. Experimen-
tal screens are often influenced by side effects in an unpredictable way. A data
mining methodology must be able to handle error-prone noisy data. Another
challenge for data mining algorithms results from the knowledge distribution of
active and inactive compounds. Usually, the number of active compounds is much
smaller than the number of inactives with differences of several orders of magni-
tude. This is especially true for the early stages of drug design projects where
typically only a handful of known active compounds are available. A data mining
method must be able to generalize well from such a small number of active tem-
plate compounds, but still be specific enough to minimize the false-positive rate.
Even the simplest classification possible, which would predict all compounds to
be inactive regardless of their properties, would yield a high accuracy! A useful
chemoinformatic method must be aware of this intrinsic bias and predict activ-
ity (or other properties) with high accuracy for both active and inactive cases.
In addition to these raw class distribution problems, chemoinformatics data sets
often have an additional structural bias. Most data sets are constructed during
compound optimization projects by chemical modification and experimental test-
ing. Thus, they contain series of analogue structures which are very similar in
their constitution and features. This places an additional bias in the data set to-
wards compounds with similar structure and makes generalization to structurally
different compounds hard to accomplish.
The adaptation of the EP framework poses three questions which are central
for this thesis:
Question 1: How can pattern mining-based knowledge be
rationalized at the molecular level?
One of the benefits of pattern-based knowledge mining is the easy interpretation
of the computed knowledge in form of class-specific combinations of attributes.
One of the earliest applications of pattern-mining has been the analysis of cus-
tomer shopping baskets (Agrawal et al., 1993) and the resulting patterns could
be rationalized by typical customer behavior, e.g. people tend to buy milk and
bread in combination. In chemoinformatics and drug discovery, researchers are
mostly concerned with structural features of ligands and their interaction with
their target protein. Successful pattern mining should lead to patterns which can
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well be rationalized chemically by relating the descriptors included in the pattern
to changes in the interactions upon formation of the protein-ligand complex.
Question 2: How does a pattern-based classifier perform on
biological data?
This question is directly related to the adaptation of the pattern mining frame-
work as a chemoinformatic tool. Chemical compounds must be represented in a
way that can be used by pattern mining algorithms, meaning transformation of
chemical information into nominal attributes.
In chemoinformatics, the focus of computational methods is often on early dis-
covery of active compounds instead of maximizing recovery rates. This is often
done by ranking large databases (compound libraries) and testing only a small
fraction of the top-ranked compounds. The standard method here is similar-
ity searching, commonly done by using bit-string representations of compounds
known as fingerprints (Auer and Bajorath, 2008). However, fingerprints are not
class-specific and the creation of class-specific similarity search methods is one of
the major research goals. The adaptation of a pattern-based data mining method
as a ranking tool would be a major contribution to similarity searching methods.
Question 3: Is it possible to integrate computational and ex-
perimental methods in an efficient way such that both meth-
ods benefit from the integration?
Virtual Screening and experimental screening are complementary methods having
specific strengths and weaknesses (Bajorath, 2002). A tight integration of both
methods into a single screening protocol is expected to dramatically reduce the
experimental effort while keeping high and early recovery (Bleicher et al., 2003).
How this integration can be established is still a question of research.
The proposed integration is relatively new and only few experiments have been
reported yet which analyze the results of such a method. Most of these experi-
ments solely analyze the performance in terms of active compound recovery but do
not look at the dynamic interplay of computational and experimental screening.
The availability of many HTS data sets released by PubChem makes it possible to
simplify integration experiments to pure computational experiments by replacing
the HTS screening phase with a simulated step based on real HTS data. In this
way, statistically valid experiments can be designed which can then be thoroughly
evaluated.
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1.3 Thesis Outline
Chapter 2 introduces the fundamental concepts of ECP mining. EPs have been
introduced recently in the data mining field by Dong et al. (1999a) and are adapted
to chemoinformatics by representing molecules using molecular descriptors. Since
ECP mining algorithms only work on discrete data ( opposite to the continuous
nature of most chemical descriptors), the chapter also describes standard dis-
cretization techniques to transform continuous descriptors into sets of discrete,
non-overlapping value-ranges. The chapter includes an introduction to EP min-
ing using the well-known example of Lipinski’s Rule of Five (Lipinski et al., 2001)
to characterize drug-like compounds and a formal definition of these patterns as
combinations of class-specific descriptor value ranges. It also gives a short de-
scription of the algorithms used in the experiments.
Chapter 3 evaluates the emerging chemical pattern approach as a tool for
chemoinformatic knowledge mining and property prediction. It shows how ECPs
are used to analyze and rationalize differences between bioactive and modeled lig-
and conformations, which answers the first research question. Compounds from
18 target classes for which crystallographic data of the binding conformations
are available are subjected to a stochastic energy minimization. Binding and
computed conformations are joined into a database which is then mined for dif-
ferentiating ECPs. The computed patterns are rationalized on a molecular basis
by analyzing differences in the interactions of the protein-ligand complexes found
in the crystallographic data and a hypothetical protein-ligand complex built by
superposing the minimized conformation on the crystallographic binding confor-
mation. Patterns described specific differences in the conformations leading to
different interaction patterns.
The second research question is addressed by exploring the possibilities of molec-
ular classification of active vs. inactive compounds using ECP-based classifiers.
ECP-based classification using 61 descriptors derived from 1D or 2D information
performs equally well as established binary classification methods. It is further
pointed out that the exploration of the exponential space of possible descriptor
value range combinations leads to classifiers which allow highly accurate classifi-
cation when the training sets are as small as six compounds (three compounds
per class).
Chapter 4 focuses on the possible integration of HTS and VS methods and shows
that ECPs can be used to perform a class-directed similarity search which selects
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compounds with similar biological properties as given by a training set, thus ad-
dressing the last research question. Two examples of iterative computational and
experimental screening protocols are described. The first simulates a possible it-
erative lead-optimization experiment which optimizes a set of compounds with
respect to potency. Sequential screening is then shown to be an efficient method-
ology integrating computational and experimental screening methods.
Chapter 5 summarizes and discusses the results. The findings in the previous
chapters are discussed with respect to the three research questions stated above.
Important aspects of each experiment are related to each of the research questions
and the implications are discussed. Finally, the thesis is summarized in short.
2 Methodology
Chemoinformatics has always been concerned with the application of new data
mining algorithms to analyse chemical and biological data and predict proper-
ties of molecules. In this thesis, a recent pattern-based approach is adapted to
chemoinformatics by using molecular data in the form of chemical descriptors.
Details of the data mining method and the adaptation to chemistry are described
in the remaining parts of this chapter. It starts with the introduction of chemical
descriptors as the basis for molecular representation. After introducing and for-
mally defining pattern-mining, emerging chemical patterns (ECP) are defined as
class-specific combinations of descriptor value ranges.
2.1 Chemical Descriptors
Molecules are represented as entries in databases, associated with numeric at-
tributes which encode molecular properties. These properties are generally called
molecular or structure descriptors. Terfloth (2003) defines structure descriptors
as “a mathematical representation of a molecule resulting from a procedure trans-
forming the structural information encoded within a symbolic representation of a
molecule”. Simple examples of such a mathematical representation are molecular
weight or formal charge which can be easily computed from the chemical formula
of a compound. These descriptors are easy to compute, but might not provide
useful information about the compounds. Many researchers have defined chemical
descriptors for different tasks with different levels of information and complexity.
The Dragon software1 currently implements more than 3200 different descriptors.
The Handbook of Molecular Descriptors (Todeschini and Consonni, 2000) lists de-
tails and definitions for these descriptors. Table 2.1 divides these descriptors into
five categories. Categories I-III relate to the molecular representation needed to
compute the descriptor value. Category IV includes descriptors which make use of
experimental data, e.g. measured binding affinities and category V includes com-
plex descriptors which are derived from combinations of other descriptors. Given
the limited amount of available experimental data, it is obvious that descriptors
1TALETE srl, http://www.talete.mi.it/dragon.htm
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Table 2.1: Classification of molecular descriptors. Molecular descriptors are partitioned
into five classes based on the molecular information needed for their computation (Auer
and Bajorath, 2008).
Type Derived from Examples
I Global (bulk) molecular properties (estimated) logP(o/w), atom counts
II 2D structure (molecular graph) structural keys, connectivity indices
III 3D structure surface properties, radius of gyration
IV Biological properties affinity fingerprints
V Combination of descriptors BCUT
of category IV are usually not available although using such data is expected to
improve the pure computational methods.
Since the biological activity of compounds is strongly influenced by 3D prop-
erties such as complementary molecular shape of ligands and binding pockets, it
would be expected that 3D descriptors are generally more sensitive to biological
activity than simpler representations. However, this is not necessarily the case.
Numerous studies indicate that 2D information is often sufficient to produce ac-
curate results (Brown and Martin, 1996; Xue and Bajorath, 2002). In addition,
2D representations are typically much less prone to errors than calculated 3D
representations. This is due to the lack of experimentally determined 3D confor-
mations of bound ligands and the insufficiency of computational methods to model
these conformations. However, when 3D information is available, type-III descrip-
tors provide much information about compounds and are certainly high-quality
features worth to be used.
The different experiments presented in this thesis use two different sets of de-
scriptors. First, a knowledge-mining experiment is described which uses type
III descriptors to investigate differences between different conformations of com-
pounds, namely conformations in binding mode and computationally generated
conformations. A second set of experiments is concerned with classification and
ranking of compounds based on their activity. These experiments utilize only 2D
information in the form of type I and II descriptors. Both descriptor sets are
described in the next two sections. The complete lists of descriptors, including a
short description of each descriptor and reference information is listed in tables
A.1 and A.2 in appendix A.
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2.1.1 Descriptor Set 1: 61 Type I and II Descriptors
The first set of descriptors consists of 61 uncorrelated type I and II descriptors se-
lected with minimized pairwise correlation and maximized information content in
a database of 1.34 million compounds (Xue et al., 2003). This set contains eleven
type I descriptors: logP(o/w), abbreviated as logP, total polar surface area TPSA
and 9 atom counts, e.g. the number of fluorine (a nF) or chlorine atoms (a nCl).
Most of the remaining 50 descriptors are type II descriptors computed from the
connectivity information encoded in the molecular graph. This set contains four
bond counts, four connectivity indices and adjacency matrix descriptors, eight
pharmacophore descriptors, 17 subdivided surface area descriptors and 17 partial
charge descriptors. The minimization of pairwise correlation effects has also pos-
itive effects on the run time of the computations because the complexity of data
mining algorithms depends on the dimensionality of the data. The list of all 61
descriptors is given in appendix table A.1.
2.1.2 Descriptor Set 2: Type III Descriptors
The second descriptor set consists of a total of 67 conformation-dependent (type
III) descriptors available in the molecular operating environment (MOE) (Chem-
ical Computing Group Inc., version 2007.09). It includes a variety of type III
descriptors belonging to five categories: energy, shape, and charge distribution
descriptors, molecular surface properties, and volume-dependent descriptors. A
subset of these descriptors including, for example, heat of formation, ionization
potential, and highest-occupied molecular orbital (HOMO) or lowest unoccupied
molecular orbital (LUMO) energies was calculated through MOE’s interface with
MOPAC (Stewart, 1990) and the semi-empirical AM1 (Dewar et al., 1985), PM3
(Dewar and Thiel, 1977) and MNDO (Stewart, 1989) methods. Partial charge and
potential energy descriptors were calculated with a MOE-internal modified ver-
sion of the Merck molecular force field (MMFF94) (Halgren, 1996a,b,c,d; Halgren
and Nachbar, 1996). The MOE implementation treats conjugated nitrogens as
planar atoms instead of tetrahedral atoms. The radius of gyration (rgyr) serves
as a measure of compactness of a molecule and the principal moments of iner-
tia (pmi, pmiX, pmiY, pmiZ) account for mass distribution. Surface descriptors
include, for example, the total solvent-accessible surface area (ASA) and posi-
tively or negatively charged (ASA+ and ASA-), hydrophobic (ASA H) or polar
(ASA P) surface areas. In addition, descriptors depending on the van der Waals
volume (vol) are also included, such as molecular density (dens) that is calculated
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by dividing molecular weight by vol. The calculation of some of these type III
descriptors, such as MOPAC descriptors, is computationally expensive. However,
all descriptors need to be calculated only once for each data set. The list of all 67
3D descriptors is given in table A.2.
All descriptor calculations are done using MOE. Prior to descriptor calculation,
the compounds are “washed” with MOE removing solvents and salts and assigning
reasonable protonation states and partial charges. The default settings of MOE
are applied.
2.1.3 Descriptor Discretization
Traditionally, pattern mining algorithms use nominal attributes instead of con-
tinuous value attributes. Most molecular descriptors are, however, continuous in
nature. One way to handle continuous attributes with pattern mining algorithms
is to transform the value range of an attribute into bins and use these bins as
new discrete attributes. The way how these bins are derived depends on the
discretization algorithm. These algorithms can be divided into supervised and
unsupervised algorithms, where algorithms from the first category use the train-
ing data to take knowledge about class and value distribution of the continuous
data into account. Unsupervised algorithms divide the value range of continuous
attributes independent of the class and value distribution of the training data set
into bins (Dougherty et al., 1995).
Unsupervised Discretization algorithms include simple equal-interval binning
where a descriptor’s value range is divided into a fixed set of intervals all spanning
the same value range. However, equal-interval binning often leads to uneven
distributions of the data into the bins, because attribute are often irregularly
distributed in their value range (Witten and Frank, 2005). An equal-interval
discretization produces many sparsely populated (or even empty) bins and a small
number of heavily populated bins, weakening the attribute’s information content.
A better unsupervised discretization technique is to derive the bins in a way that
all bins contain the same number of attributes, irrespective of their class value.
This equal-frequency binning produces a fixed number of equally populated bins.
However, since it is still an unsupervised method which does not use the class
distribution of the training data available, the resulting binning scheme can also
lead to a loss of information, e.g. when the equal-frequency constraint forces a
split point between two bins in a way that the first bin is pure, i.e. containing
only compounds from one class, but the second bin starts with a small number
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of instances from the one class and then contains only instances of another class.
In this case, giving up the equal-frequency constraint to produce two pure bins
would be favorable.
Supervised Discretization techniques make use of the class distribution of the
training instances, e.g. by using statistical error measures such as the χ2 test
(Kerber, 1992; Kohavi and Sahami, 1996) or information theory (Fayyad and
Irani, 1992). The information theory based discretization from Fayyad and Irani
(1992) has shown good results in several applications of EP mining (Li and Wong,
2002a,b; Ramamohanarao and Bailey, 2003) and is subsequently used as the stan-
dard discretization algorithm.
The information theory based discretization algorithm utilizes information en-
tropy as a measure of pureness for a possible splitting point. In this way, it is
similar to the attribute splitting criterion used in decision tree learning (Quin-
lan, 1993) and extends this idea to a recursive algorithm to successively split a
continuous attribute into bins until a stopping criterion is reached. The stop-
ping criterion is based on the minimum description length (MDL) principle and
ensures that the number of bins stays reasonably small. The method starts by
examination the information entropy of all possible splitting points2. The class
information entropy induced by a splitting point T which split an attribute A and
training data S into two intervals S1 and S2 is defined as
E(A, T, S) =
|S1|
|S| Ent(S1) +
|S2|
|S| Ent(S2),
with Ent(S) = −Σ|C|i=1P (Ci, S) log(P (Ci, S)) being defined as the entropy of a
dataset S with n classes C = {C1, . . . , Cn}. P (Ci, S) gives the proportion of
instances in S with class Ci. After computing the information entropy of each
splitting point, the one with the minimum class information entropy is selected
and the algorithm recursively discretizes both sides of the induced partitioning.
An additional benefit of the information entropy based discretization is that
the MDL principle stops the recursion in the first iteration if no good splitting
point can be found and thus returns a binning with one bin spanning the whole
value range of (−∞,∞). Such attributes provide no information for classification
and can thus be removed prior to pattern mining, reducing the dimensionality of
the pattern space and computation time.
2A possible splitting point is located only in the middle between two subsequent values from
the training set.
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Table 2.2: A sample data set with ten compounds and four calculated descriptors: molec-
ular weight (MW), logP(octanol/water) (logP), the number of hydrogen bond acceptors
(HB-acc) and donors (HB-don). Each descriptor is discretized into two intervals.
Class MW logP HB-acc HB-don
[0, 500) [500,∞) (−∞, 5] (5,∞) [0, 10] (10,∞) [0, 5] (5,∞)
1 active × × × ×
2 active × × × ×
3 active × × × ×
4 active × × × ×
5 inactive × × × ×
6 inactive × × × ×
7 inactive × × × ×
8 inactive × × × ×
9 inactive × × × ×
10 inactive × × × ×
2.2 Mining Emerging Patterns
The following sections introduce the concepts and notions of EP mining using a
toy data set and then formally define the relevant concepts.
2.2.1 Mining Patterns Related to the Rule of Five
The formal concept of emerging patterns will be introduced in the following using
the well known example of Lipinski’s rule of five (Lipinski et al., 2001). For this
purpose, consider the model data set reported in table 2.2 that consists of 10
compounds and four descriptors: molecular weight (MW), logP(octanol/water),
the number of hydrogen bond acceptors (HB-acc), and the number of hydrogen
bond donors (HB-don). The descriptors have been divided into two intervals.
Four of the hypothetical compounds are active and the remaining six are inactive.
The example data shows that a single descriptor interval is not sufficient to
describe the difference between active and inactive compounds. However, using
combinations of some of the descriptors might lead to a discriminatory descriptor
value range selection. In this example, it would be possible to test all combinations
by hand, but for large numbers of descriptors and compounds, due to the expo-
nential growth in possible combinations, a computational method that searches
the space of all descriptor value range combinations for class-specific patterns is
employed. A pattern is simply any combination of descriptor value ranges, e.g. the
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Table 2.3: Emerging chemical patterns for active compounds computed from the sample
data set in Table 2.2
Growth Supportactive Supportinactive Pattern
3 0.5 0.17 {HB-don:[0.00,5.00]}
3 0.5 0.17 {MW:[0.00,500.00), logP:(−∞,5.00],
HB-acc:[0.00,10.00]}
single descriptor value range {MW:[0.00,500.00]} or a more complex combination
of descriptors such as, for example, molecular weight with the number of hydrogen
bond donors: {MW:[0.00,500.00],HB-acc:[0.00,10.00]}. Patterns that are specific
for the active compounds should only rarely occur in inactive ones. How often
a pattern p occurs in a data set D is measured by the support suppD(p) as the
percentage of compounds that match the pattern. The support of the pattern
{HB-don:[0.00,5.00]} in the sample data is 24 for the active class and 16 in the
inactive class. A class-specific pattern can be defined as a pattern where the frac-
tion of both supports, called growth rate, is larger than a defined threshold. The
pattern p has a growth rate growthactive,inactive(p) = 3. A class-specific pattern
is called emerging pattern (Dong et al., 1999a). From all possible EPs, those are
especially interesting which are of smallest cardinality. The previously shown pat-
tern p could be changed by adding an additional descriptor value range, thereby
altering the supports in both classes and thus the growth rate. However, adding
an additional descriptor value range also makes the pattern more selective and
probably reduces the number of matched compounds for the new pattern. Each
compound that is matched by the modified pattern is also matched by the origi-
nal pattern, and thus p subsumes the more specific pattern. In other words, the
pattern p is more general than any pattern that can be constructed by adding
one or more additional descriptor value ranges. Table 2.3 shows the EPs specific
for the active compounds. Given these patterns, one would conclude that active
compounds have a molecular weight lower than 500 Da, a logP(octanol/water)
below five, not more than 10 hydrogen bond acceptors, and not more than five
hydrogen bond donors.
2.2.2 Formal Definition of Emerging Chemical Patterns
The concept of emerging patterns will be defined formally in the following sections.
Pattern mining is concerned with data sets of sets instances, each being a subset
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of a fixed set I of items I = {i1, . . . , in}. A pattern (or item set) is simply a
combination of these items:
Definition 2.2.1 A pattern P is a combination of items found in a data set:
P ⊆ I.
A pattern matches an instance d of a data set S if each item of the pattern is
also part of that instance, i.e. P ⊆ d.
Given two data sets S1 and S2, the support and growth rate of a pattern P can be
defined.
Definition 2.2.2 The support supp of a pattern P in a data set S is the percent-
age of instances matched by P :
suppS(P ) =
|{d|d ∈ S ∧ P ⊆ d}|
|S|
For two data sets S1 and S2, the growth rate growth of a pattern P is defined
as the fraction of support in both data sets:
growthS1,S2(P ) =

suppS1 (P )
suppS2 (P )
, if suppS2(P ) > 0
∞, else
The above definition does not define a growth rate for patterns with zero support
in the home class S1. However, these patterns are not of interest for data mining
and thus attributes with zero support in S1 are removed before pattern mining.
A pattern which is rare in one class, e.g. S2, but common to its home class S1 is of
particular interest from a data and knowledge mining perspective. These patterns
are called emerging patterns. Patterns with infinite growth rate (patterns which
occur only in one class but not in the other) are called jumping emerging patterns
(Dong et al., 1999a):
Definition 2.2.3 Given a threshold t ≥ 0, a pattern P with a growth rate
growthS1,S2(P ) ≥ t is a t-emerging pattern. A ∞-emerging pattern is called
jumping emerging pattern (JEP).
The set of all t-emerging pattern for a data set grows exponentially with the
number of possible items. To reduce the number of patterns for a knowledge
mining experiment, only patterns which balance specificity and generality are
retained and the remaining patterns are pruned. A pattern maximizes generality
if it matches as many instances in its home class data set as possible. This is
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Figure 2.1: Most expressive jumping emerging pattern. A small data set of 11 com-
pounds from two classes (red and blue) is projected into a space of two attributes
D1 and D2. Each attribute is discretized into two intervals. {D1:(1,2),D2:(b,c)} and
{D2:(a,b)} are most expressive jumping emerging patterns.
done by selecting patterns with minimum cardinality. Increasing the cardinality
of a t-emerging pattern P by adding an additional item increases the number of
restrictions an instance must fulfill to be matched and thus is likely to decrease the
number of matched instances in the home class of P . Specificity is maximized by
t-emerging patterns with large growth rate. Of special interest in this regard are
jumping emerging patterns because they provide the sharpest distinction between
two classes of data. From the set of all jumping emerging patterns, most expressive
jumping emerging patterns, as defined by Li et al. (2001) are especially interesting:
Definition 2.2.4 A jumping emerging pattern P , computed from two data sets
S1 and S2 is most expressive if and only if
1. Each proper subset of P is no longer a jumping emerging pattern:
∀p ⊂ P.growthS1,S2(p) 6=∞
2. Each proper superset of P has smaller support in P ’s home class S1:
∀p ⊃ P.suppS1(P ) > suppS1(p)
Figure 2.1 illustrates the concept of the most expressive emerging pattern using
a small set of eleven compounds labeled by color with two classes (red and blue).
The pattern {D1:(1,2), D2:(b,c)} is a JEP of minimum cardinality. Both subsets
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{D1:(1,2)} and {D2:(b,c)} match compounds from both classes and are thus not a
JEP anymore. Since it already uses all possible descriptors in the data set, it also
fulfills the second requirement for most expressive JEPs. Another example is the
pattern {D2:(a,b)}. This pattern is a JEP for the class of red compounds. Having
a cardinality of 1, it easily fulfills the first requirement of most expressive JEPs.
If the pattern is extended by a adding second attribute, the support decreases.
As an example, consider the extended pattern {D2:(a,b), D1:(3,4))}, where the
support decreases from 78 to
5
8 . Thus, any larger pattern built from {D2:(a,b)}
has lower support in the red class and {D2:(a,b)} is a most expressive JEP.
2.2.3 Mining Algorithms
The development of algorithms for mining emerging patterns is a field of active
research and has produced a number of algorithms with different properties. Many
algorithms use so-called borders to store large sets of patterns in a compact way
and use the border-diff algorithm (Dong et al., 1999b) to compute the set of all
jumping emerging patterns of two data sets. The efficiency of the border-diff
operation depends on the dimensionality of the positive and negative examples as
well as on the number of negative examples. Various approaches exist which try
to optimize the use of border-diff to improve the efficiency of emerging pattern
mining, including tree-based approaches (Bailey et al., 2002) and a hypergraph-
based approach (Bailey et al., 2003). These algorithms all work in a divide-
and-conquer approach and try optimize the usage of the border-diff operation.
Other approaches for mining emerging patterns include tree-based approaches
which use search trees to explore the space of possible patterns (Zhang et al.,
2000b), sometimes using additional pruning techniques to remove uninteresting
patterns early in the search process (Fan and Ramamohanarao, 2003). A recent
implementation uses zero-suppressed binary decision diagrams and is shown to be
one of the fastest algorithms available (Loekito and Bailey, 2006).
Although a number of fast algorithms are available, the problem of mining
emerging patterns remains computationally hard. It is shown to be MAX-SNP–
hard (Wang et al., 2005a). The MAX-SNP complexity class contains graph-
theoretical prolems which can be described by existential second-order logic. It
has been shown that fixed-ratio approximation schemes for these problems are
also NP-hard (Papadimitriou and Yannakakis, 1988).
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2.2.4 Classification
Emerging Patterns can be used to construct high-performance classifiers. Ra-
mamohanarao and Bailey (2003) provide an overview of most of the algorithms.
For classification, a set of emerging patterns is first computed for each class. If
the data set contains more than two classes, a round robin approach (Fu¨rnkranz,
2002) can be used. Round-robin computes patterns for each class by using all
other classes as a merged background class. A test compound is then classified
based on which set of patterns it resembles more. The actual implementation of
the decision function differs for each algorithm, but most algorithms aggregate
the support of all patterns matching the test instance for each class and then as-
sign the class with largest aggregated support (Li et al., 2001, 2004; Zhang et al.,
2000a).
A general outline of the classification procedure is shown in figure 2.2. First
the training data set, which consists of 20 compounds divided into two classes by
color code and two attributes, is mined for JEPs. After an optional pruning step,
some of these JEPs are stored for classification of unknown test compounds. Two
test compounds are shown. The accumulated support is computed for each test
compound by checking which JEP matches the test compound. In this example,
the first test compound matches two JEPs from the red class and only one JEP
from the blue class. The second test compound matches one JEP from each
class. Based on the sum of support for these patterns, the first test compound is
predicted to belong to the red class, while the second test compound is predicted
to belong to the blue class.
2.3 Emerging Chemical Patterns
Emerging pattern mining provides a powerful technique to extract important
knowledge from data sets and use this knowledge to analyze data or to predict
properties of new, unknown test data. It is straightforward to combine emerging
pattern mining with molecular data represented as molecular descriptors. Since
pattern mining only works for discrete attributes, the continuous descriptors first
have to be transformed into discrete attributes by means of discretization algo-
rithms. The supervised, information theory based discretization technique has
been shown to yield good results in several applications of EP based classification
studies (Li et al., 2004; Li and Wong, 2002a; Ramamohanarao and Bailey, 2003)
and is the preferred method used in the experiments described in the following
chapters. However, the unsupervised discretization methods are also evaluated
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(a) 20 compounds projected into a two-dimensional descriptor space. Red
and blue indicate the compound class.
Pattern Support
p1={D1:[3,4),D2:[a,b)} 5/11
. . .
pi={D1:[3,d),D2:[d,e)} 1/9
pi+1={D1:[1,2),D2:[c,d)} 1/11
. . .
pn={D1:[3,4),D2:[c,d)} 3/9
(b) Emerging chemical patterns com-
puted from the data set in (a).
(c) Classification of two unknown test compounds using
the ECPs stored in table (b).
Figure 2.2: Outline of the classification procedure using a JEP based classifier. A data
set of 20 compounds, divided into two classes, is projected into a chemical reference
space of two descriptors D1 and D2. From this space, ECPs are mined and stored in a
table. For classification of unknown test compounds, each pattern is tested wether is
matches the test compound and the supports of matching patterns are summed.
Two example test compounds are shown in (c). The first compounds matches patterns
p1, pi+1 and pn. The cummulated support is 6/11 for the red class and 3/9 for the blue
class. Thus, this compound is predicted to belong to the red class. The second test
compound matches patterns pi+1 and pn and has cummulated supports of 1/11 and
3/9 for the red and blue class, respectively. It is labeled to belong to the blue class.
CHAPTER 2. METHODOLOGY 21
in the classification experiments described in section 3.2, and a simple binning
scheme based on statistical properties is used in the simulated sequential screen-
ing experiment described in section 4.2.1.
Emerging chemical patterns (ECP) are based on combining chemical informa-
tion in the form of chemical descriptors and pattern mining. A specific descriptor
value range is written as a pair D : (min,max), where D denotes the descriptor
name and min and max define the lower and upper bound of the value range.
Round parenthesis and square brackets are used as to distinguish between open
and closed intervals. A compound matches a descriptor value range if the corre-
sponding descriptor value for that compounds lies between the lower and upper
boundaries of the interval.
Definition 2.3.1 A chemical pattern (CP) cp is a combination of 1 ≤ i ≤ n
descriptor value ranges, where each descriptor Di occurs only in one descriptor
value range:
cp = {D1 : (min1,max1), . . . , Dn : (minn,maxn)}.
A set of descriptor value ranges S is matched by a chemical pattern cp if and
only if each descriptor value range of cp is also present in S: cp ⊆ S.
A chemical pattern cp is a t-emerging chemical pattern (ECP) for two data sets
D1 and D2 if it has a growth rate larger than t:
growthD1,D2(cp) ≥ t.
Based upon the concept of most-expressive jumping emerging patterns, jumping
emerging chemical patterns (JECP) (Auer and Bajorath, 2006) are defined as
most-expressive jumping emerging patterns computed from discretized chemical
compound data represented as chemical descriptors. As described in section 2.2.4,
classification is based on most-expressive JECPs only.
Two mining algorithms are used to extract ECPs from chemical data sets. For
the virtual screening experiments and the simulated sequential screening in chap-
ter 4, a hypergraph based algorithm developed by Bailey et al. (2003) was used
which computes all JECPs for a data set of two classes. Classification is done by
accumulating the supports of all patterns for a class which are present in the test
compound’s descriptor data. The knowledge mining experiment on 3D confor-
mations in section 3.1 utilizes the zero-suppressed binary decision diagram based
algorithm from Loekito and Bailey (2006) to compute all t-emerging patterns in-
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stead of only jumping emerging patterns. Given the fact that the biological data
here is highly imbalanced (a few active compound are usually compared to large
compound databases), accumulated supports are normalized by dividing it by the
maximum possible accumulated support for each class.
3 ECP Data Mining and Classification
A variety of machine learning methods are used in chemoinforamtics research.
Typical applications include analyzing biological data sets, e.g. results of HTS
campaigns, or predicting properties based on training sets with experimentally
measured biological data.
This chapter describes two experiments used to validate and explore the poten-
tial of the ECP methodology in chemoinformatics. It is first shown that ECPs
capture class-specific features in a high-resolution manner even if the underlying
compounds are structurally highly similar and differ only in their 3D conforma-
tion. Computed patterns are validated on a molecular level to show the validity of
the ECP mining approach. In a second experiment, ECPs are used to construct
accurate classifiers on the basis of very small training sets. ECP-based classifi-
cation is evaluated using four different compound sets. The prediction accuracy
based on training sets of different size is compared to two established classifica-
tion methods, namely a decision tree (DT) implementation and a Bayesian-based
binary QSAR (BIN) classification technique, both implemented in MOE.
3.1 Data Mining for Conformational Differences
One feature of patterns is their simplicity as combinations of class-specific de-
scriptor value ranges and thus the possibility to interpret and relate patterns to
features of the molecules. knowledge mining for differences between two or more
compound sets by analyzing biological data is one of the major applications of
data mining algorithms in chemo- and bioinformatics. EPs have already been
shown to extract useful knowledge out of gene expression data (Li and Wong,
2002a,b). These findings motivated an experiment where the aim was to find
distinguishing patterns that reflect the differences of experimentally determined
binding (bioactive) conformations of ligands compared to computationally pre-
dicted conformations. Sadowski (2003) reviews many methods for computing
binding conformations, starting from early algorithms to compute the conforma-
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tions of six-membered rings to state-of-the-art methods like Corina1 or Omega2.
A deeper understanding of the differences between computed and bioactive bind-
ing conformations would greatly increase the quality of 3D structure generation
programs. Additional knowledge could be used to filter out conformations which
are not similar to bioactive conformations or could directly be incorporated into
rule- and data-based methods.
Over the past decade, several studies have investigated binding conformations
of known active compounds, mostly enzyme inhibitors, taken from complex crys-
tal structures (Agrafiotis et al., 2007; Bostrøm et al., 1998; Diller and Merz, 2002;
Nicklaus et al., 1995; Perola and Charifson, 2004; Stockwell and Thornton, 2006).
A major focal point of these investigations has been the analysis of intramolecular
strain energy of small molecules that is generally induced upon protein binding.
It is well appreciated that ligands do not bind in global energy-minimum confor-
mations to their targets because achieving a high degree of molecular complemen-
tarity within a binding or active site generally comes at the cost of steric strain.
The strain energy penalty associated with the formation of protein-ligand com-
plexes can be approximated by computational means. For example, depending
on the force field used to calculate relevant energy terms, Perola and Charifson
(2004) have estimated total strain energy of average small molecular ligands to
be approximately 2 kcal/mol. Steric strain effects contribute to the difficulties
associated with correctly predicting bioactive ligand conformations, which is of-
ten attempted by systematic conformational sampling and filtering of low energy
conformers. It is therefore not surprising that strain energy and its consequences
have been intensely studied.
Going beyond the analysis of strain effects, only very few studies have attempted
to systematically explore differences between binding and modeled conformations.
For example, in a pioneering study reported in 2002, Diller and Merz compared
65 small molecules taken from X-ray structures of protein-ligand complexes to
5000 low energy conformations. For each experimental and corresponding energy-
minimized conformations, the distribution of the values of six type III (three-
dimensional) descriptors was compared. These descriptors included polar and
apolar solvent-accessible surface area, the radius of gyration, dipole moment, the
number of intermolecular interactions, and the ratio of two principal molecular
axes. It was found that binding conformations tended to have larger solvent-
accessible surface area than minimized conformations because of fewer intramolec-
1http://www.molecular-networks.com/software/corina
2http://www.eyesopen.com/products/applications/omega.html
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ular interactions. Binding conformations were in general also found to be less
compact than energy-minimized ones.
One would hope that systematic comparisons of bioactive and modeled ligand
conformations for different targets might ultimately help to identify active con-
formations in conformational ensembles, which is of paramount importance for
reliable 3D structure generation and thereby various ligand-based drug design
strategies, e.g. QSAR modeling or pharmacophore analysis. This would require
to deduce target-specific rules or feature combinations that could differentiate be-
tween alternative conformations. The ability to capture even subtle differences
between highly similar compounds makes knowledge mining using ECPs a promis-
ing tool to follow up on the theme of the analysis by Diller and Merz. In the
experiment presented in this chapter, ECP mining is evaluated for its potential
to identify compound class-specific descriptor value range patterns (i.e. signature
patterns) that distinguish bioactive conformations from other low energy conform-
ers with high accuracy. Inhibitors of 18 target proteins were studied and in each
case, ECP mining identified patterns that correctly identify bioactive conforma-
tions and differentiate them from others, even if conformational differences were
subtle. Furthermore, key patterns could be rationalized at the molecular level of
detail by analyzing X-ray structures of enzyme-inhibitor complexes.
3.1.1 Data Set
The data set is assembled from the PDBbind database (Wang et al., 2004, 2005b),
an online accessible compilation of protein-ligand complexes extracted from the
Protein Data Bank (PDB, release No. 107, January 2004). Ligand selection is
done from the “refined” subset of the PDBbind, which provides high-quality ligand
structures selected for comparison of structure-based virtual screening methods.
This subset contains only X-ray crystallography structures3 with a resolution of
at least 2.5 A˚. Only binary complexes, i.e. complexes formed by one protein and
one ligand molecule, with non-covalently bound ligands and known equilibrium
constants were added to the set. Additionally, ligand molecules are restricted
to contain only the most common organic elements C, N, O, P, S, F, Cl, Br, I,
and H and to have a molecular weight less than 1000 Da. The compounds in
this set were divided into activity classes based on their target protein, and 18
classes (all enzymes) were selected because these classes have a reasonable number
of different ligands. Table 3.1 summarizes these 18 classes. The class size ranges
3NMR structures were not included since they only accounted for 39 out of 1622 candidate
structures.
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Table 3.1: Reported are the number of inhibitors with experimental binding conforma-
tions per class (Cmpds) and the number of modeled low energy conformers, their RMSD
range relative to the corresponding experimental conformation, the average RMSD per
class, and the number of emerging chemical patterns (Patterns) that discriminate be-
tween bioactive and modeled conformations.
Class Cmpds Modelded
conformers
RMSD
range
RMSD
average
Patterns
Acetylcholine esterase 5 16 0.69 - 5.39 2.69 15
Adenosine deaminase 15 139 1.10 - 4.18 2.45 17
Carbonic anhydrase 21 198 0.57 - 4.30 2.26 36
Carboxypeptidase 8 60 0.73 - 5.03 2.71 17
Cyclin-dependent kinase 31 247 0.70 - 4.08 2.24 7
Elastase 3 30 1.59 - 4.09 2.69 81
Endothiapepsin 6 19 3.30 - 5.87 4.80 33
Factor Xa 10 91 0.94 - 5.68 2.52 32
FK506 binding protein 6 51 1.82 - 4.23 3.06 15
HIV protease 20 142 0.98 - 6.27 3.69 8
Plasminogen activator 7 43 0.25 - 2.76 1.69 8
PT Phosphatase1b 14 67 0.30 - 4.58 2.40 17
Protocat.-dioxygenase 10 16 0.08 - 3.39 0.87 10
RibonucleaseA 9 45 0.98 - 3.39 2.12 10
Thermolysin 6 42 2.05 - 4.95 3.30 197
Thrombin 21 158 0.60 - 4.51 2.69 7
Trypsin 30 195 0.33 - 3.37 1.74 5
Tyrosine kinase 5 23 2.72 - 5.47 3.95 30
from three for elastase to 31 for cyclin-dependent kinase (CDK). On average, each
class contains ∼13 conformations.
Each active compound was subjected to extensive conformational search us-
ing the Molecular Operating Environment (MOE, version 2007.09). A stochastic
conformational search was carried out for 10,000 iterations by randomly rotating
single bonds in test molecules. Following each iteration, the resulting conforma-
tion was energy-minimized and sampled. Cartesian minimization was carried out
using MOE’s MMFF94x force field until the RMS gradient of the energy function
was less than 0.001 kcal/(mol× A˚). For each inhibitor, sampled low energy con-
formations were compared in order to eliminate conformations from pairs of very
similar ones, applying a root mean square deviation (RMSD) threshold value of
0.1 A˚. As reported in table 3.1, between 16 and 247 low energy conformations
were retained per class with an average of 88 conformations. RMSD values for
modeled and experimental conformations were calculated based on superposition
of all non-hydrogen atoms. In 12 of 16 cases, the conformational ensembles con-
tained conformers that were very similar to binding conformations, i.e. within
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(a) Adenosine deaminase inhibitors
(b) Adenosine deaminase inhibitors
(c) Ribonuclease A inhibitors
(d) Trypsin inhibitors
Figure 3.1: Exemplary bioactive and modeled conformations. The binding conforma-
tions (on the left) and corresponding low energy conformers (right) are shown for four
inhibitors of three enzymes discussed in the text. The dashed line represents an in-
tramolecular hydrogen bond. (a) and (b) adenosine deaminase inhibitors (taken from
PDBbind entries “1fkx” and “1ndv”, respectively), (c) ribonuclease A inhibitor (1afk),
(d) trypsin inhibitor (1o3h).
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1 A˚ RMSD. Thus, in many cases, differences between experimental and modeled
conformations were rather subtle, which can also be appreciated in figure 3.1.
However, all ensembles also contained conformations that deviated from binding
conformations by several A˚ RMSD. Most classes produced an average RMSD of
around 2 A˚, suggesting that modeled conformers were overall not dramatically
different from binding conformations. The sampled conformations represent a
spectrum of conformers provides a good basis for the analysis of the ability of
ECPs to capture class-specific knowledge about the differences in bioactive con-
formations.
3.1.2 Methodology
Pattern Mining
The experiments described herein are based on differences in the spatial arrange-
ments of molecules. In order to capture differences in their 3D properties, the set
of type III descriptors described in section 2.1.2 was used as the basis for pattern
mining. Prior to descriptor calculation, the compounds were normalized by first
aligning their three principle molecular axes to the x-, y- and z-axis in descend-
ing order. Afterwards, the molecules were translated such that their center of
mass matched the origin of the coordinate system. This minimized the influence
of translational and rotational differences for descriptors depending on external
coordinates.
For ECP mining, the descriptors were first discretized using the supervised
information entropy-based discretization method. A fast implementation of ECP
mining based on zero-suppressed binary decision diagrams (Loekito and Bailey,
2006) was then used to compute all ECPs matching given support thresholds in
bioactive and modeled classes. For bioactive conformations, a support threshold of
min. 50% was applied, meaning that patterns matching at least half of the binding
conformations were calculated. For modeled conformations, a threshold of max.
10% was applied. These parameter settings ensured that each detected pattern
was at least five times more frequent in bioactive than in modeled conformations.
For each inhibitor set, all patterns with a growth rate of at least 10 were analyzed.
Protein-Ligand Complex Depiction
For the interpretation of key patterns, details of protein-ligand interactions in the
X-ray structures of their complexes were studied and represented with the aid of
two-dimensional (2D) interaction diagrams (Clark and Labute, 2007) calculated
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with MOE. These diagrams provide a 2D abstraction of the interactions between
a ligand and its target protein and are used extensively in section 3.1.4 to analyse
the interactions of conformations. In the interaction diagrams, the active site re-
gion is delineated as an envelope. Amino acids are color-coded according to polar,
negatively charged, and positively charged (pink, red, and blue, respectively) and
hydrophobic (green) character. Solvent-exposed residues and ligand atoms have
additional shading (light and dark blue, respectively). Hydrogen bonds are drawn
as dashed donor-acceptor arrows and are colored green if they involve a protein
side chain or blue if they involve backbone atoms. Green dashed lines containing
aromatic ring symbols indicate donor interactions with pi-electron systems or pi-pi
interactions. Metal contacts are displayed in magenta. For comparison, mod-
eled low energy conformers were superposed on experimental conformations of
each inhibitor and interaction diagrams were also analyzed for these hypothetical
complexes. Superposition was done by matching of non-hydrogen atoms in both
conformations. These hypothetical complexes were used to interpret patterns in
structural terms instead of pure statistical analysis.
Two experiments were done using the methodology and data set described
above. First, ECPs were used to discover global differences in bioactive and
energy-minimized conformations. A second set of experiments further investigated
these differences on a per-class basis. Patterns were rationalized based on the
interactions formed upon formation of the ligand-protein complexes.
3.1.3 Differences Between Modeled and Bioactive Conformations
Assessing the global differences between modeled and bioactive conformation has
been the focus of several studies during the last years. These studies have con-
firmed that modeled ligands generally have more compact sphere-like conforma-
tions, while bioactive conformations tend to elongated out to form energetically fa-
vorable ligand-protein interactions, e.g. hydrogen bonds, or to compensate charge
distributions. This leads to an induced strain energy in the ligand itself. Ad-
ditionally, bioactive conformations tend to have a larger surface-area and less
intramolecular interactions, e.g. internal hydrogen bonds (Diller and Merz, 2002;
Perola and Charifson, 2004). These findings should also be reflected in the pat-
terns computed from the set of all bioactive and inactive conformations and thus
provides a useful proof-of-concept experiment for ECP knowledge mining on 3D
conformations prior to analyzing descriptor patterns for individual classes.
ECPs were computed from the combined data set of all 227 bioactive conforma-
tions and 1598 low-energy conformations. The three patterns with largest growth
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Table 3.2: Emerging chemical patterns for discriminating the combination of all bioactive
from all modeled conformations. The growth of the most discriminatory patterns is
reported. “B” stands for bioactive/binding and “M” for modeled conformations.
Growth B [%] B M [%] M Pattern
1364.14 86 195 0 1 {E strain:(24.46,∞]}
75.95 67 152 1 14 {E str:(14.90,∞]}
29.22 31 71 1 17 {E:(147.95,∞]}
rate are reported in table 3.2. Only the first two patterns met the predefined sup-
port threshold levels of min. 50% support for bioactive conformations and max.
10% support for low-energy conformations. Both patterns discriminate effectively,
given the magnitude of their growth rates, and clearly reflect the general intro-
duction of ligand strain energy upon complex formation, regardless of the nature
of the interactions. The strain energy pattern was dominant with a growth rate
of 1364, followed by the bond stretch energy pattern having a growth rate of 76.
The third pattern in table 3.2 with lower growth indicates that the total poten-
tial energy of binding conformations was generally higher compared to minimized
conformations, which is of course also expected. This pattern has a support rate
of only 1% in the energy-minimized conformations and is thus very specific for
bioactive conformations. However, its support rate of 31% in the bioactive con-
formation class makes it less general than specified by the stringent threshold of
50% for the bioactive class. The overall diversity of the ligands in the data set
and the high growth rate of almost 30 rationalize the inclusion of this pattern in
the global analysis.
At the chosen level of support stringency, only patterns were identified that
referred to strain or total energy as generally discriminating features. Patterns
relating to differences in shape, e.g. compactness measures, were not found because
the high ligand diversity prevented shape-related patterns from achieving a high
support of at least 50%. However, the global comparison of binding and modeled
conformations on the basis of emerging chemical patterns produced meaningful
results highlighting the well-known strain energy penalties.
3.1.4 Class-based Pattern Mining
The global analysis has shown that ECP was able to compute reasonable and
discriminating patterns to distinguish bioactive from low-energy conformations.
These global patterns were simple general rules to discriminate conformations
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based on energetic properties, mainly strain and bond-stretch energy penalties.
A class-level analysis of computed ECPs is motivated by the high diversity of
the data set and the different binding modes of the included inhibitors. Different
binding modes result in different chemical properties and thus in different ECPs.
However, the overall diversity makes it hard to satisfy the support threshold for
bioactive conformations. A second set of experiments thus investigated the ability
of ECP mining on a per-class basis. In this experiment, only conformations from
one of the 18 activity classes were used as a database for ECP mining to compute
class-specific ECPs discriminating bioactive from low-energy conformations.
Table 3.1 reports the number of class-specific patterns that were obtained, given
the applied support stringency threshold, which ranged from five for trypsin to
197 for thermolysin inhibitors. In most cases, between approximately 10 and
30 patterns were obtained. In general, the more diverse experimental binding
conformations are, the fewer widely applicable signature patterns are identified.
Patterns for three representative sets are reported in tables 3.3 to 3.5 and dis-
cussed in detail in the next section including a discussion of the conformational
differences in the corresponding ligand conformations and their influence on the
interactions of the induced protein-ligand complex. Patterns for all remaining
classes, including the four classes discussed in the following text are reported in
appendix D. As expected, strain energy and related patterns were found in all
cases. However, for each of the 18 inhibitor sets, different types of signature pat-
terns also emerged. Most patterns were relatively small including only one to five
descriptor value ranges, with the exception of the thermolysin set that produced
patterns with up to nine descriptors. This set also generated the largest number
of patterns, which is not surprising, given the fact that increasing numbers of de-
scriptors lead to an exponential growth in the possible number of patterns. These
tables show that the majority of signature patterns had infinite growth, which
means that they exclusively occurred in bioactive, but not modeled reference con-
formations. Therefore, these patterns were highly specific. In many instances,
patterns consisting of a single energy descriptor were found to be highly discrimi-
natory. Among these were torsion and out-of-plane energy descriptors whose value
ranges were indicative of in part significant distortions of inhibitors upon binding.
However, patterns containing no energy term descriptors were also found in most
cases and usually consisted of combinations of at least two descriptors. For exam-
ple, the pattern {CASA+:(1956.91,∞], FCASA-:(1.40,3.21], pmi:(10083.21,∞]}
discriminated bioactive factor Xa inhibitor conformations from inactive confor-
mations. This pattern combines charge distributions on the solvent-accessible
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surface area with the principal moment of inertia (a descriptor of general mass
distribution). For ligands of the FK506 binding protein, angle bending energy
and hydrophobic solvent accessible surface area displayed value range preferences
for bioactive conformations, but the individual descriptors only partly discrimi-
nated between bioactive and modeled conformations. However, a pattern com-
bining these preferred value ranges perfectly classified these conformers. Sim-
ilar patterns combining energy term descriptors with surface area, charge, or
shape features were found to be prominent for many classes. For example, for
protein tyrosine phosphatase 1b inhibitors, the pattern {ASA P:(210.39,282.26],
E ele:(−11.07,∞], E tor:(1.88,∞]} combines two energy descriptors with polar
solvent-accessible surface area and has infinite growth rate. Other examples in-
clude ribonuclease A inhibitors where a combination of the dipole moment and
electrostatic energy leads to patterns with infinite growth rate. In some cases,
even relatively simple geometric descriptors were found to be highly discrimina-
tory. As an example, for protocatechuate-3,4-dioxygenase, simple shape measures
such as the extension along a molecular axis effectively distinguished between
bioactive and modeled conformations. In this case, the inhibitors are small (sub-
stituted benzenes). Upon binding to the enzyme, substituents are forced out of
the aromatic ring plane, due to a structural constraint caused by a bound cation,
which significantly alters the shape of these small inhibitors. Energy minimization
of these ligands without the presence of the cation places the substituents in an
energetically favourable planar position and thus leads to smaller extension along
the vertical principle axis.
Taken together, pattern analysis for individual compound classes revealed that
highly discriminatory patterns of variable composition were identified in each
case. These target-specific patterns accurately distinguished between bioactive
and modeled conformations of inhibitors.
3.1.5 Structural Interpretation of ECPs
The quantitative analysis in the previous section has demonstrated that binding
conformation sensitive patterns could be systematically identified for a variety of
target sets. A further attempt to rationalize the validity of the pattern mining
approach was to go beyond statistical analysis of discriminatory patterns and at-
tempt to relate them to details of protein-ligand interactions. For ECPs, this
meant to relate signature patterns to changes in the interactions between protein-
ligand complexes formed by the bioactive ligand conformation and a hypothetical
protein-ligand complex formed by a low-energy conformation. The low-energy
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protein-ligand complexes were computed by superposition of the low-energy lig-
and and the bioactive conformation taken from the X-ray crystallographic data.
However, key interactions were expected to differ as a consequence of confor-
mational differences that are a prerequisite for highly discriminatory signature
patterns. As shown in the previous sections, binding conformations contain sev-
eral energy penalties (e.g. strain or bond-stretch energy) compared to low-energy
conformations.
The remaining part of this section presents an analysis of three representative
cases, inhibitors of adenosine deaminase, ribonuclease A, and trypsin, for which
small and intuitive discriminatory patterns were identified. Figure 3.1 shows the
bioactive and modeled conformations of inhibitors used to generate exemplary
complexes. The examples will illustrate that modeled conformations of the in-
hibitors studied here could not have been used to correctly predict details of the
enzyme-inhibitor interactions, even if pose information was available. However,
the analysis shows that key conformational differences can be well rationalized
with the aid of discriminatory descriptor patterns.
Adenosine Deaminase Inhibitors
Adenosine deaminases is a metallo-enzymes that catalyzes the deamination reac-
tion of adenosine to inosine. The active site contains a zinc cation that is involved
in the activation of a water molecule during catalysis (Cristalli et al., 2001). Ta-
ble 3.3 reports the signature patterns for adenosine deaminase inhibitors.
Typical strain and bond stretch energy descriptors displayed increased values
for binding conformations. In addition, increased out-of-plane and angle bend-
ing energies were characteristic for the majority of binding, but for none of the
modeled conformations. Ring distortions were detected in all inhibitors with
available crystallographic binding conformations. Figure 3.2a shows the active
site together with the bound ligand as taken from the crystallographic data and
figure 3.3a shows the interactions of this complex. The hypoxanthine ring sys-
tem is twisted in order to position the carbonyl oxygen above the ring plane,
which results in high out-of-plane and angle bending energies. In this position,
the carbonyl oxygen strongly interacts with the zinc cation and thereby inhibits
the enzyme. Figure 3.3b shows the corresponding hypothetical complex. In the
modeled inhibitor, the ring system is planar and not distorted, which prevents
the interaction between the carbonyl oxygen and the zinc cation.
Figure 3.3c shows the crystallographic complex formed by a chemically different
adenosine deaminase inhibitor that contains three rings. All three ring systems
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(a) Binding site and ligand conformation of the crystal-
lographic 1fkx protein-ligand complex. The active site
of adenosine deaminase contains a zinc cation (shown
in yellow) that catalyzes the deamination of adenosine
by activating a water molecule. The inhibitor interacts
with the zinc cation, resulting in a distorted hypoxan-
thine ring system.
(b) Binding site and ligand conformation of the crystal-
lographic 1ndv protein-ligand complex. The ligand oc-
cupies several hydrophobic pockets in the active site of
adenosine deaminase. This requires high shape comple-
mentary and results in twisted ring conformations of the
ligand.
Figure 3.2: Binding sites and ligand conformations for two adenosine deaminase inhibitor
conformations from crystallographic data. The color scheme in (a) visualizes the partial
charge of the binding pocket. Red and blue encode the charge of the pocket, from
negatively (red) to positively charged areas (blue). In (b), the color-code visualizes
possible interactions of the binding pocket. Hydrophobic areas are colored in green,
purple encodes possible hydrogen bonding sites and blue weakly polar areas.
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(a) X-ray structure of an adenosine deami-
nase inhibitor complex (1fkx). The inhibi-
tor complexes a zinc cation that activates a
water molecule during catalysis. The con-
tact is formed through a distorted hypox-
anthine ring system.
(b) The corresponding protein-ligand hypo-
thetical protein-ligand complex with a low
energy conformer. Here the hypoxanthine
ring is planar, which prevents the zinc con-
tact, and fewer interactions are formed.
(c) Structure of another adenosine deaminase-
inhibitor complex (1ndv). Distorted ring
systems (with large calculated out-of-plane
energy penalty) match hydrophobic binding
pockets and present a guanidino group for
an array of salt bridge interactions.
(d) The corresponding protein-ligand hypo-
thetical protein-ligand complex with a low
energy conformer. In the modeled confor-
mation, the rings are planar, the guanidino
group is re-positioned, and the salt bridge
interaction can no longer be formed.
Figure 3.3: Experimental and modeled adenosine deaminase interactions. Protein-ligand
interaction plots are described in section 3.1.2. Ligand conformations are shown in
figure 3.1.
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Table 3.3: Discriminatory patterns for adenosine deaminase inhibitors. “B” stands for
bioactive/binding and “M” for modeled conformations.
Growth B [%] B M [%] M Pattern
∞ 93 14 0 0 {E strain:(24.46,∞]}
∞ 80 12 0 0 {E str:(14.90,∞]}
∞ 53 8 0 0 {E tor:(1.88,∞], std dim2:(1.81,∞]}
∞ 53 8 0 0 {E tor:(1.88,∞], pmiY:(1141.06,∞]}
∞ 53 8 0 0 {E oop:(1.64,∞]}
∞ 53 8 0 0 {E ang:(17.54,∞]}
∞ 100 15 0 0 {E strain:(15.69,∞]}
∞ 87 13 0 0 {E str:(10.26,∞]}
∞ 73 11 0 0 {E ang:(13.51,∞]}
∞ 53 8 0 0 {E stb:(0.96,∞]}
138.00 100 15 1 1 {E:(55.17,∞]}
32.20 93 14 3 4 {E oop:(0.25,∞]}
27.60 60 9 2 3 {E tor:(1.88,∞], E vdw:(28.30,72.89]}
24.53 53 8 2 3 {E tor:(1.88,∞], PM3 HF:(−85.25,69.90]}
24.53 53 8 2 3 {E tor:(1.88,∞],
MNDO HF:(−79.25,169.85]}
occupy hydrophobic pockets and significantly contribute to the binding affinity
(Terasaka et al., 2004), as can be seen in figure 3.2b. The mode of inhibition is
completely distinct from the previously discussed inhibitor in this case. It does
not involve complexation of the zinc cation, as discussed above, but rather forms
interactions between a guanidino group of the inhibitor and catalytic residues.
In its bound conformation, all three rings of the inhibitor are twisted to vary-
ing degrees. The largest contribution to the out-of-plane energy results from a
deformation of the benzimidazol-2-amino moiety where the amino substituent is
moved out of the ring plane. The ring distortions are an apparent consequence
of achieving a degree of shape complementarity while correctly positioning the
guanidino group for strong salt bridge and hydrogen bonding interactions with
aspartic acid and histidine residues. Figure 3.3d shows the corresponding hypo-
thetical complex. The modeled ligand with planar ring systems can no longer
form the strong interactions via the guanidino group and achieves overall lower
shape complementarity, although the benzimidazol ring penetrates deeper into
the hydrophobic F2 pocket.
Thus, in the case of adenosine deaminase, signature patterns were identified
for a compound set containing chemically distinct inhibitors with different modes
of action that discriminated between bioactive and modeled conformations with
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Figure 3.4: Binding site and ligand conformation of the crystallographic 1afk protein-
ligand complex. The active site of ribonuclease A contains several positively charged
binding pockets designed for RNA phosphate groups. These pockets are occupied by
phosphate groups from the inhibitor, which results in high shape complementarity
and places hard constraints on the binding conformation of ribonuclease A inhibitors.
Colors encode the charge of the binding site from positive (blue) to negative (red)
partial charge.
high accuracy. This was possible because the inhibitors were conformationally
perturbed in similar ways upon binding, although their structures and interactions
were distinct.
Ribonuclease A inhibitors
For ribonuclease A inhibitors, strain and bond stretch energy were not the most
discriminatory patterns. As reported in table 3.4, other descriptors were found to
perfectly discriminate between bioactive and modeled conformations.
Signature patterns contained the van der Waals energy as a single descriptor
as well as combinations of the dipole moment and various electrostatic energy
term descriptors. The comparison of binding conformations with van der Waals
energy values matching the signature pattern and the corresponding modeled con-
formations revealed that the increase in van der Waals energy in the low energy
conformers resulted from the formation of an intramolecular hydrogen bond in-
volving one of the phosphate groups (figure 3.1c) that was not observed in the
binding conformation. Figure 3.4 shows the binding pocket of the ribonuclease
A protein together with the crystallographic binding conformation of the inhibi-
3.1. DATA MINING FOR CONFORMATIONAL DIFFERENCES 38
Table 3.4: Discriminatory patterns for ribonuclease A inhibitors. “B” stands for bioac-
tive/binding and “M” for modeled conformations.
Growth B [%] B M [%] M Pattern
∞ 78 7 0 0 {E vdw:(−∞,28.30]}
∞ 56 5 0 0 {AM1 dipole:(17.34,∞],
PM3 Eele:(−755075.90,−335581.90]}
∞ 56 5 0 0 {AM1 dipole:(17.34,∞],
MNDO Eele:(−788514.20,−336721.10]}
∞ 56 5 0 0 {AM1 Eele:(−783413.80,−340732.90],
AM1 dipole:(17.34,∞]}
∞ 78 7 0 0 {E vdw:(−∞,32.76]}
∞ 67 6 0 0 {E strain:(32.31,∞]}
∞ 67 6 0 0 {E stb:(−0.36,∞]}
∞ 56 5 0 0 {E str:(9.28,∞]}
∞ 56 5 0 0 {E:(92.14,∞]}
29.33 67 6 2 1 {E strain:(24.46,∞]}
6.11 56 5 9 4 {AM1 dipole:(17.34,∞],
ASA+:(−∞,227.75],
PM3 E:(−124393.40,−95187.02],
dipoleZ:(−1.24,∞]}
6.11 56 5 9 4 {AM1 dipole:(17.34,∞],ASA+:(−∞,227.75],
MNDO E:(−158562.00,−105111.10],
dipoleZ:(−1.24,∞]}
4.89 56 5 11 5 {dipoleX:(−∞,−1.59], glob:(0.08,0.10]}
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(a) Interactions of a ribonuclease A inhibitor com-
plex (1afk). Binding of the phosphate groups is
stabilized by multiple salt bridges and hydrogen
bonds.
(b) The corresponding protein-ligand hypothetical
complex. Many of the key interactions are ab-
sent.
Figure 3.5: Interactions of experimental and modeled ribonuclease A conformations.
Protein-interaction plots are described in section 3.1.2. Figure 3.1 shows the two lig-
and conformations and figure 3.4 shows the lingand in the binding site of the crystal-
lographic complex.
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tor 1afk. The phosphate groups of ribonuclease A inhibitors occupy positively
charged regions in the active site that accommodate the phosphate groups of the
RNA substrate (Yakovlev et al., 2006). Figure 3.5a shows the interactions of the
X-ray structure of a ribonuclease A-inhibitor complex. In its binding conforma-
tion, the inhibitor positions the phosphate groups to strongly interact with the
histidine and lysine residues in the phosphate binding pockets, thereby achiev-
ing charge complementarity. In the corresponding hypothetical complex shown
in figure 3.5b, the phosphate groups are positioned differently and many of the
interactions seen in the crystal structure can no longer be formed. Here signature
patterns correctly detected a conformational artifact that led to a more compact
inhibitor structure that would not have been capable of forming the electrostatic
interactions within the active site.
Trypsin inhibitors
Trypsin inhibitors represent an interesting test case for pattern analysis. Diller
and Merz (2002) found that bioactive trypsin inhibitor conformations were par-
ticularly difficult to distinguish from minimized conformations because binding
conformations also displayed strong intramolecular interactions between ring sys-
tems. However, as shown in table 3.5, besides the general increase in strain
and bond stretch energy, two discriminatory patterns with single descriptors
emerged, accounting for bond stretching/angle bending cross term energy and
the z-component of the principal moment of inertia.
Trypsin inhibitors matching these patterns contain a diamino methyl sub-
stituent at an indol ring (figure 3.1d). In its binding conformation, the diamino
methyl substituent is co-planar with the indol ring (figure 3.6), which correctly
positions the amino groups for well-defined hydrogen bonding and electrostatic
interactions (figure 3.7a). This conformation has a low z-component of the princi-
pal moment of inertia because most atoms are positioned in or near the indol ring
Table 3.5: Discriminatory patterns for trypsin inhibitors. “B” stands for bioac-
tive/binding and “M” for modeled conformations.
Growth B [%] B M [%] M Pattern
∞ 100 30 0 0 {E strain:(5.11,∞]}
∞ 63 19 0 0 {E str:(10.03,∞]}
∞ 63 19 0 0 {E stb:(0.53,∞]}
24.25 50 15 2 4 {pmiZ:(−∞,16.69]}
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Figure 3.6: Binding site and ligand conformation of the crystallographic 1o3h protein-
ligand complex. Trypsin is a protease catalyzing the hydrolysis of peptide bonds at
positively charged residues. The negative asparagine in the S1 pocket recognizes these
residues. The inhibitor interacts with this asparagine through axial diamino groups.
(a) Trypsin-inhibitor complex (1o3h). The
diamino methyl substituent is in a strained
equatorial conformation that enables the
formation of multiple salt bridge and hy-
drogen bonding interactions.
(b) The corresponding hypothetical com-
plex. Here the diamino methyl group is
in energetically preferred axial orientation,
which breaks the crystallographic interac-
tion pattern.
Figure 3.7: Interactions of experimental and modeled trypsin conformations. Figure 3.6
shows the binding site of the crystallographic complex. Colors encode the charge of the
binding site from positive (blue) to negative (red) partial charge. Protein-interaction
plots are described in section 3.1.2. Ligand conformations are shown in figure 3.1.
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plane of the molecule. Figure 3.7b shows the corresponding hypothetical complex.
In the modeled conformation, the diamino methyl moiety is rotated such that the
amino groups are orthogonal to the indol ring, which increases the value of z-
component of the principal moment of inertia. However, this orientation would
break the network of crystallographic interactions involving the diamino methyl
substituent.
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3.2 ECP Classification
In early stages of hit-to-lead or lead-optimization programs, the amount of avail-
able training data is rather limited. Additionally, biological data is often biased
towards inactive compounds because only a small set of all possible chemical com-
pounds shows desired biological properties, e.g. activity against certain targets.
This situation has motivated the development of a novel classification approach
that could also be applied in these situations, for example, when attempting to
guide compound selection or design on the basis of only a few reference molecules.
Traditionally, such efforts have been supported by qunatitative structure-activity
relationship (QSAR)-type methods (Esposito et al., 2004) to quantitatively model
structure-activity relationships and predict analogues having improved potency.
However, QSAR methods also require high-quality training data sets containing
as many compounds as possible, which are often not available when analyzing
novel hits or leads.
Additionally, a high-quality computational model decreases the number of
screening experiments in early stages of drug discovery and helps to focus on
compounds with desired properties. Experimental screening is expensive in both
time and money, constituting as much as 15% to the total research and develop-
ment budget of pharma companies (Klopack, 2000). Consequently, reducing the
number of screens also reduces the costs and time of drug-discovery programs.
Although this chapter focuses on the prediction of potency, other properties, e.g.
toxicity or ADME properties, could also be predicted, ruling out compounds in
early stages which otherwise would have been included and eliminated in later
stages of the drug discovery program.
3.2.1 Data Set
The experiments in this chapter use a total of four classes of compounds with
experimentally measured binding affinities to different targets. These classes are
assembled from public sources and contain compounds covering greatly varying
potency distributions: benzodiazepine receptor (BZR) ligands, inhibitors of dihy-
drofolate reductase (DHFR), glycogen synthase kinase (GSK3) and HIV protease
inhibitors (HIVPROT). The first two sets are taken from a QSAR study done
by Sutherland et al. (2003). The other two sets have been extracted from the
BindingDB database (Chen et al., 2002). In all data sets, potency is measured
as half maximal inhibitory concentration (IC50) values. IC50 is the amount of a
compound needed to bind to half of the target molecules present in the experi-
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Figure 3.8: Potency distribution within compound activity classes. Shown are box plots
for each activity class (see table 3.6). In these plots, boxes show the 0.75 (top) and
0.25 quartile (bottom) separated by the median (horizontal bar). The lines indicate
the largest and smallest values (falling within a distance of max. 1.5 times the box size
from the nearest hinge).
Table 3.6: Compound classes and potency levels. Compound potencies are reported as
IC50 values ; “n” is the number of compounds per class and the next two columns report
how many of these compounds have IC50 values below or above 1µM; “max”, “min”,
and “avg” give the highest, lowest, and average compound potency, respectively.
class n ≤ 1µM > 1µM max. min. avg.
BZR 321 283 38 0.00034 250.00 2.02
DHFR 586 249 337 0.0023 929.00 16.67
GSK3 464 281 183 0.0008 1000.00 12.84
HIVPROT 967 821 146 0.000015 200.00 2.68
ment. The composition and potency distribution of the data set is summarized
in table 3.6. All sets contain more than 300 compounds with measured potencies,
but the distribution of highly potent (IC50 ≤ 1µM) and weakly potent com-
pounds (IC50 > 1µM) varies. The BZR and HIVPROT sets are dominated by
compounds with potency (small IC50), reflected by high average and minimum
potency. Potencies in the other two sets are more equally distributed, with a
bias for weakly potent compounds in DHFR and a bias towards compounds with
high potency in GSK3. Figure 3.8 further illustrates the potency distribution in
each class in the form of boxplots. Each class spans a range of three orders of
magnitude. For DHFR, GSK3 and HIVPROT, the potency distribution is cen-
tered somewhere around the 1µM threshold between highly and weakly active
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Figure 3.9: Representative structures for the four compound classes used in the classi-
fication and virtual lead optimization experiments. For each activity class, the most
and least potent compounds are shown together with one having an IC50 value equal
or close to the median.
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compounds, whereas the compounds in BZR show a smaller IC50 value and thus
a higher potency.
Figure 3.9 shows representative structures for each class. It can be seen that the
inter- and intra-class similarity of the classes is rather low. This diversity makes
them a challenging and interesting set for the evaluation ECP classification.
3.2.2 Evaluation
In all experiments, the set of 61 uncorrelated, information rich descriptors de-
scribed in section 2.1.1 is used. This set covers a wide range of descriptors, but
does not utilize any 3D information of the compounds.
The first experiment is a proof-of-concept experiment that validates the accu-
racy of the ECP classifier compared to standard approaches in chemoinformatics.
The ECP approach was applied to classify compounds belonging to either the
sets with potency above or below an IC50 value of 1µM and compared to binary
QSAR and decision trees, as implemented in MOE. As described in section 2.2.4,
classification is based on most expressive jumping ECPs (JECPs) only. For each
classification, training sets of increasing size (10–50% of compounds belonging to
each activity class) were selected. For binary QSAR, subsets of most suitable de-
scriptors are selected by applying MOE contingency analysis prior to model build-
ing. For classification, a probability threshold value of 0.5 was applied for each
compound to belong to the higher potency class. For decision trees, the 61 pres-
elected descriptors available in MOE were evaluated during the tree construction
process. The constructed tree was post-processed in a pruning step to remove not
required attributes and increase general applicability. Two trees were constructed
in a 2-fold cross-validation step and the best one was selected as the final decision
tree structure. For all three methods, classifiers were trained on 500 randomly
selected sets, the resulting models applied to predict the potency-dependent class
label of the remaining compounds and average accuracies calculated. Initially,
training sets containing 10–50% of compounds per class were used.
In a second series of calculations, classifiers derived from training sets of very
small size are analyzed, only consisting of three, five, or 10 compounds per class
from each potency range, corresponding to ∼0.6–6% of the compounds in the
activity classes. This presents a typical lead optimization scenario where only a
few active compounds are available as an information source for predictions.
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Table 3.7: JECPs for activity class GSK3. JECPs with highest support are reported
for a single training calculation on a total of 25% GSK3 compounds. In this example,
descriptor value intervals were determined using the linear binning scheme.
(a) JECPs for IC50 ≤ 1µM compounds.
support JECP
0.37 {PEOE VSA-3:(7.32,10.98]}
0.35 {PEOE VSA+3:(5.94,11.88], a nS:(−∞,0.20],
vsa don:(8.71,13.07]}
0.35 {PEOE VSA+2:(7.94,15.89], PEOE VSA-4:(−∞,4.72]}
0.34 {SMR VSA2:(15.31,22.96], SlogP VSA3:(−∞,11.06],
VDistEQ:(3.19,3.44]}
0.34 {PEOE VSA+2:(7.94,15.89], PEOE VSA+3:(5.94,11.88]}
0.34 {PEOE VSA+2:(7.94,15.89], vsa don:(8.71,13.07]}
0.32 {SMR VSA2:(15.31,22.96], SlogP VSA3:(−∞,11.06],
SlogP VSA5:(−∞,12.28], a nF:(−∞,0.30]}
0.32 {SlogP VSA3:(−∞,11.07], SlogP VSA6:(−∞,0.44],
VDistEQ:(3.19,3.44], a nS:(−∞,0.20]}
0.32 {PEOE VSA+6:(−∞,3.84], SlogP VSA3:(−∞,11.06],
SlogP VSA5:(−∞,12.28], VDistEQ:(3.19,3.44]}
0.32 {PEOE VSA+3:(5.94,11.88], a nBr:(−∞,0.30],
vsa don:(8.71,13.07]}
(b) JECPs for IC50 > 1µM compounds.
support JECP
0.48 {SlogP VSA0:(−∞,7.169], a nBr:(−∞,0.3],
vsa don:(−∞,4.356]}
0.46 {a nBr:(−∞,0.30], vsa don:(−∞,4.36], vsa pol:(−∞,5.17]}
0.46 {a don:(−∞,0.60], a nBr:(−∞,0.30]}
0.39 {SMR VSA3:(−∞,3.35], SlogP VSA8:(−∞,9.43],
a nBr:(−∞,0.30]}
0.39 {PEOE VSA+3:(−∞,5.94], a don:(−∞,0.60]}
0.39 {PEOE VSA+3:(−∞,5.94], vsa don:(−∞,4.34]}
0.37 {PEOE VSA+5:(−∞,4.06], SlogP VSA0:(−∞,7.17],
SlogP VSA8:(−∞,9.43], a nBr:(−∞,0.30],
b triple:(−∞,0.10]}
0.37 {PEOE VSA+4:(−∞,3.94], PEOE VSA+5:(−∞,4.06],
SlogP VSA0:(−∞,7.17], a nBr:(−∞,0.30]}
0.37 {SMR VSA3:(−∞,3.35],
a nBr:(−∞,0.30],vsa don:(−∞,4.36]}
0.37 {SlogP VSA0:(−∞,7.17], SlogP VSA4:(−∞,5.55],
vsa don:(−∞,4.36]}
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Comparison of Classification Methods
The initial test if ECPs are able to capture the differences between nano- and
micro-molar compound sets is an analysis of the JECPs generated during training
from a data set containing a random sample of 25% of each nano- and micro-
molar compounds of class GSK3. It has already been shown that ECPs can
capture class-specific information based on type III descriptors, but this time,
only 2D information is available. Table 3.7 reports the ten JECPs with highest
support for both classes. In this test calculation, an unsupervised equal-width
discretization scheme was applied for demonstration purposes.
ECPs are chemically intuitive and can be easily interpreted. For example, the
top JECP for the ≤ 1µM class consists of a single descriptor range and occurs
in 37% of the compounds of this class but none of the other. Another interest-
ing JECP is the pattern {a don:(3.6,4.2]}4, accounting for hydrogen bond donors,
having a support of 11% in the ≤ 1µM class. In the > 1µM class, patterns
involving descriptors counting the number of bromine atoms and hydrogen bond
donors with small value ranges are prominent and occur in direct combination
in the pattern {a don:(−∞,0.6], a nBr:(−∞,0.3]} with 46% support. In addi-
tion to the top 10 patterns reported in table 3.7, the number of sulfur atoms
is also identified as a discriminating feature ({a nS:(1.8,∞]} with 17% support)
as is the limited polar surface area within the range 28.81–41.83, captured by
the JECP {TPSA:(28.81,41.83]} with a support of 22%. Figure 3.10a shows the
top GSK3 compounds predicted to belong to the ≤ 1µM class and reveals accu-
rate predictions; only one compound was incorrectly classified. This false-positive
prediction can easily be explained when considering the training data. The nu-
merical descriptors were divided into 10 equal-size intervals, which represents a
low resolution encoding assigning exactly the same intervals to the missclassified
compounds 1 and 3 in figure 3.10a. Thus, the classifier considered them identical
molecules. The top 10 GSK3 compounds predicted to belong to the > 1µM class
are shown in figure 3.10b. Here three of 10 compounds were misclassified. The
ECP classifier correctly inferred that thiadiazolidinone (TDZD) derivatives have
potency > 1µM, although the GSK3 data set only contained 29 TDZD derivatives
with IC50 values between 2 and 100µM. Thus, ECPs were highly discriminatory
even for relatively underrepresented chemotypes. These calculations were then re-
peated applying information entropy based descriptor discretization. The top 10
4The floating-point thresholds in the descriptor value range are the result of the unsupervised
discretization. The equal-width discretization algorithm has divided the value range [0, 6]
into ten equal-width intervals.
CHAPTER 3. ECP DATA MINING AND CLASSIFICATION 49
N
H
O
HN
Br
O
H
N
O
NH
Br
N
HO
22µM 0.005µM
H
N
O
NH
O
Br N
N
N
H
HN
O
Cl
0.045µM 0.234µM
H
N
O
NH
O
Cl
N HN
N
HN
O
Cl
0.14µM 0.27µM
H
N
O
NH
O
I
N
N
N
H
H
N
O
0.055µM 0.425µM
N
N
N
H
HN
O
OH
N
N
H
HN
O
O
0.036µM 0.035µM
(a) unsupervised, ≤ 1µM
O
O
N
N
S
Br
O
HN
N
Br
3µM 0.4µM
HN
O
HN
Br
N
HN
O
N
HN
Br
0.018µM 6µM
O
O
N
N
S
Cl
O
HN
N
H
F
4µM 0.08µM
O
HN
N
H
O
O
O
N
N
S
2.2µM 5µM
O
O
N
N
S
N
O
O
N
S
3µM 6µM
(b) unsupervised, ≤ 1µM
Figure 3.10: Top-ten compounds predicted to belong to the nano-molar ((a) and (c))
and micro-molar class ((b) and (d)) from a sample run of the ECP classification using
a training set of 25%. (a) and (b) are the result of an unsupervised discretization of
descriptors prior to JECP mining. (c) and (d) show the top ten compounds resulting
from supervised (information entropy based) discretization. Potency is printed in µM .
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Figure 3.10: continued.
CHAPTER 3. ECP DATA MINING AND CLASSIFICATION 51
compounds for each predicted class are shown in subfigures 3.10c and 3.10d. Here
the classifier achieved 100% accuracy, both for “nano-molar” and “micro-molar”
compounds. These findings demonstrate the predictive value of patterns derived
from descriptor settings subjected to entropy-based discretization and rationalize
the usage of the supervised discretization as the primary discretization algorithm
in the following comparison.
The analysis of JECPs in the last section showed that ECPs can capture class-
specific knowledge and are well suited for classification of compounds based on
molecular descriptors. The following paragraphs evaluate the performance of
ECP-based classification (ECP) compared to a DT classifier and the BIN classifi-
cation algorithm, both implemented in the MOE software package. The decision
tree is constructed by a recursive procedure which adds one branch-point to the
tree, similar to the supervised information-entropy based discretization method.
Each branch point is a decision rule splitting the current data set into two parts
based on a cut value c for one particular molecular descriptor. The descriptor and
cut point c are chosen to maximize the purity of the induced partitions. The MOE
implementation uses the Gini index of diversity as a measure for pureness. It is
defined as it(t) = ΣxΣy,x6=yp(x|t)p(y|t) for a node t and classes x and y. p(x|t)
gives the proportion of class x in node t. The procedure stops when no cut point
with increasing pureness is found. The constructed decision tree can be pruned
by removing nodes in the tree to increase the generalization potential. Unpruned
trees are likely to be adapted to the training data, producing high accuracy on
known examples, but lower accuracy on unknown test data due to overfitting.
The BIN method is based on Bayesian statistics (Labute, 1999). It estimates the
class probability based on estimated descriptor value distributions. Opposed to
ECP and DT, it assigns a probability p for a compound to belong to the class
of nano- or micro-molar compounds (with probability 1 − p). This probability
is transformed into a binary class label by a probability threshold of 0.5 for the
nano-molar class. Descriptor selection for BIN classification is done prior to model
creating by contingency analysis implemented in MOE.
The comparison is done on training sets of different size ranging from 10% to
50% of the available compounds. The results are reported in table 3.8. For these
training sets consisting of relatively large fractions of the data sets, all three clas-
sifiers performed almost equally well, achieving overall prediction accuracy at the
80% level. In fact, it was interesting to see that the difference in performance
between these methods was very small for all four activity classes. Surprisingly,
performance hardly changes from 10–50%. Prediction accuracy was consistently
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Table 3.8: Average prediction accuracies for five training set sizes (10–50% of each
activity class) are reported for ECP, binary QSAR (BIN), and decision tree (DT)
classification. The last row reports the average accuracy over all classes.
training set size
10% 20% 30% 40% 50%
class ECP BIN DT ECP BIN DT ECP BIN DT ECP BIN DT ECP BIN DT
BZR 0.82 0.78 0.85 0.85 0.67 0.83 0.86 0.73 0.84 0.86 0.77 0.85 0.87 0.80 0.85
DHFR 0.64 0.66 0.62 0.67 0.69 0.65 0.67 0.70 0.67 0.67 0.70 0.68 0.67 0.71 0.68
GSK3 0.76 0.77 0.79 0.78 0.81 0.82 0.79 0.82 0.83 0.79 0.82 0.84 0.80 0.82 0.85
HIVPROT 0.89 0.78 0.84 0.89 0.84 0.85 0.89 0.86 0.86 0.89 0.87 0.87 0.89 0.88 0.86
average 0.78 0.75 0.78 0.80 0.75 0.79 0.80 0.78 0.80 0.80 0.79 0.81 0.81 0.80 0.81
lowest for DHFR (approximately 60–70%) and highest for HIVPROT (approxi-
mately 80–90%), irrespective of the methodology.
The former evaluation showed that ECP classification is comparable to stan-
dard chemoinformatics methods. The next paragraph focuses on predictions based
on very small training sets of 10 or fewer compounds. It was thought that ECP
should be well suited to operate under such unusual training conditions because
of the high level of resolution emerging chemical patterns displayed in compound
ranking. Thus, it should be possible to extract discriminatory patterns from only
a few compounds. Therefore, for each activity class training sets of 10, 5, or 3
compounds were assembled from each of the ≤ 1µM and > 1µM potency classes
by random selection and predicted the class label of the remaining compounds.
The results are presented in table 3.9. Under these challenging training conditions,
ECP performed better than BIN or DT classification, in three cases still reach-
ing approximately 80–90% average prediction accuracy for training on only three
compounds. Overall, ECP performed best on three compound sets and BIN on
one. For the smallest learning sets, decision tree classification lost any predictive
ability, because it classified all compounds as highly potent, yielding an artificial
prediction accuracy of 100% for the ≤ 1µM class, but 0% for the > 1µM class.
For three of our classes, BIN showed slightly better results for prediction of com-
pounds from the ≤ 1µM class than ECP. However, for all classes, the prediction
accuracy for compounds from the > 1µM class was clearly below random, thus
indicating the presence of systematic prediction errors. Thus, BIN could not be
applied in a meaningful way to these test cases when only three compounds were
used for training. For training sets composed of five compounds, where appar-
ent systematic prediction errors were absent, the prediction accuracy of ECP was
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Table 3.9: Average prediction accuracies are separately reported for both potency classes
and very small training sets of three, five, or 10 compounds from each class. Abbrevi-
ations are used according to table 3.8.
training set size
3 5 10
class ECP BIN DT ECP BIN DT ECP BIN DT
a) ≤ 1µM
BZR 0.62 0.72 1.00 0.75 0.58 0.57 0.74 0.57 0.59
DHFR 0.54 0.68 1.00 0.72 0.54 0.58 0.73 0.71 0.59
GSK3 0.57 0.74 1.00 0.80 0.64 0.68 0.82 0.51 0.69
HIVPROT 0.79 0.73 1.00 0.78 0.65 0.63 0.81 0.57 0.66
b) > 1µM
BZR 0.88 0.45 0.00 0.75 0.55 0.64 0.79 0.58 0.63
DHFR 0.75 0.39 0.00 0.55 0.55 0.50 0.59 0.44 0.50
GSK3 0.86 0.44 0.00 0.68 0.52 0.65 0.72 0.70 0.62
HIVPROT 0.57 0.45 0.00 0.61 0.52 0.59 0.65 0.62 0.63
significantly higher than for DT and BIN calculations. Thus, overall only ECP
calculations displayed consistent predictive ability for very small training sets.
3.3 Discussion
This chapter established the potential of using ECPs as a data mining tool on
molecular data. ECPs were calculated from a data set of crystallographic and
computed energy-minimum conformations and used to systematically detect com-
pound class-specific features that differentiate bioactive and modeled compound
conformations. As a first result, strain and bond-stretch energy penalties were
found in computed conformations. These finding where consistent with earlier re-
sults and can be rationalized by induced changes in the ligand conformations upon
ligand binding. However, signature patterns of individual classes contained more
information and accounted for class-specific differences. For each of 18 different
compound classes, several highly discriminatory patterns were identified based on
a pool of 67 type III (3D) descriptors. Signature patterns typically consisted of
only one to three descriptor value ranges. Signature patterns could be well ratio-
nalized on the basis of available structural data and used to distinguish between
hypothetical and experimentally observed protein-ligand interactions. This shows
that ECP data mining is well suited for biological applications. Conformational
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changes are related to changes in the interaction network of the protein-ligand
complex. These differences place constraints on the binding conformations which
are reflected by corresponding patterns. This directly relates to the first research
question posed in the introductory chapter. For the discrimination between bioac-
tive and modeled conformations, this question could be answered by relating key
patterns to changes in the protein-ligand interaction network induced by the con-
formational differences reflected by the patterns.
In addition to distinguishing between experimental and modeled binding con-
formations, it is conceivable that descriptor pattern analysis can also be used to
identify binding conformations of novel active compounds and targets for which
experimental conformations of other ligands are already available. If no exper-
imental conformations are available, binding conformations of other ligands can
not be predicted. A prerequisite for the success of this analysis is that underlying
protein-ligand interactions are similar. ECP knowledge mining and classification
could be used to improve 3D structure generation programs in two ways. First,
it is possible to amend rule-based structure generation programs by class-specific
rules generated from 3D ECPs. Second, an ECP-based classifier could be used
to refine a set of computed conformations by eliminating conformations which do
not contain key patterns as a pattern filter. This would require that the known
conformations have the same binding mode as the compound for which a new
conformation is to be generated.
In the future, it is hoped that the positive results of ECP knowledge mining can
be repeated on data from docking calculations. Finding discriminating patterns
between bioactive conformations and conformationally different computed confor-
mations from docking programs would be of great benefit for further development
of docking algorithms. Similar to 3D structure generation, patterns could be used
as filters after the docking process to remove conformational artifacts or directly
be incorporated into the docking algorithm, e.g. to modify the scoring function.
In a next step after knowledge mining, a second experiment has shown that
the encouraging results of ECP-classification from data mining in bioinformatics
applications could be transferred to chemoinformatics applications. The experi-
ments have shown that classification based on JECPs performs as well as BIN and
DT based classification in the prediction of relative compound potencies, directly
answering research question two. The ability to handle very small training sets is
the distinguishing feature of ECP classification compared to established methods.
Even sets containing only three to five highly active and weakly active (or inac-
tive) compounds are sufficient to build a predictive ECP model which can then
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be used to identify other potent molecules or predict the potency level of newly
designed compounds. These features make the ECP approach attractive to aid in
analogue design during early stages of lead optimization where molecular infor-
mation is usually rather limited and where often too few molecules with different
potencies are available to build conventional QSAR models. These early stages
often include the design of combinatorial libraries based upon a small number
of known active compounds, which are then evaluated experimentally. An ECP
classifier, trained from a small set of known active compounds, could easily be
incorporated into a combinatorial library design process to remove weakly active
compounds, resulting in a smaller library which is then evaluated. In this way,
experimental resources for testing the compounds can be saved by cherry picking
and a larger region of the chemical analogue space can be inspected (Bleicher
et al., 2003).
Traditionally, activity prediction is the domain of QSAR methods. Different
from classical QSAR approaches, ECP does not attempt to predict actual activity
values. Rather, it is trained to predict compounds to be active above or below a
predefined potency threshold level and is thus conceptually more similar to binary
QSAR analysis. The ECP classifier extends the feature space of the compounds
from single descriptors to a space constituted by the combination of class-specific
descriptor value range combinations. This leads to a higher resolution and also
increases the features available for classification. This increased feature space
could be one of the reasons for the superior performance on very small training
sets. The general nature of the ECP classifier makes it also easy to adopt the
procedure for classifying compounds not only for potency, but also for different
properties, e.g. toxicity or absorption, distribution, metabolism, and excretion
(ADME) properties. A predictive model early in the process of drug design would
be a valuable tool for reducing the fail ratio for developing drugs. The good
performance in predicting potency levels indicates that ECP could also be used
as a predictive tool for other properties with high accuracy.
Recently, it has been shown that EP classification can also benefit from ensemble
classification. Here, ensembles of many classifiers are trained on samples subsets
of the available training data set and the output of all classifiers is combined into
a single prediction. With small changes in the scoring function, Fan et al. (2006)
show that the accuracy improves significantly on 14 of 27 test sets when using an
ensemble of 51 EP classifiers. This suggests that ECP classification would also
benefit from ensemble classification and perform significantly better than using
a single ECP classifier, at the cost of additional training and classification time.
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However, on very small training sets, methods such as boosting (Freund, 1990;
Schapire, 1990) and bagging (Breiman, 1996) cannot be used because they are
based on building ensembles of classifiers using statistical samples selected from
the available training data. In light of the superior performance of ECP classifi-
cation on very small training sets, this certainly is a small drawback. In addition
to ensemble classification, the presented classification could also benefit from the
inclusion of ECPs with finite growth rate. The conformation mining results sug-
gest that patterns with large but finite growth rate have high information content
and would provide relevant knowledge about the differences in the two data sets
to the classifier and improve classification accuracy.
Despite its encouraging performance, the ECP approach also has some general
limitations. First, ECP classifications are qualitative in nature, and the com-
puted scores do not reflect absolute differences in potencies and are thus not
appropriate for potency-based compound ranking. Furthermore, for large train-
ing sets, ECP calculations become computationally expensive. Mining ECPs is
an NP-hard problem, meaning that the computational time grows exponentially
with the number of compounds and descriptors used. Finally, ECP predictive
accuracy is influenced by the degree of similarity of training compounds. If the
compounds are highly similar, the probability is high that many descriptors will
be discretized into only one range and thus be eliminated by the information-
based discretization technique, which in turn makes it difficult to identify highly
discriminatory patterns. However, this problem also reflects a unique strength of
the ECP approach, its ability to derive sound predictive models on the basis of few
compounds having different structural features yet similar activity. This suggests
that ECP can be successfully applied to predict highly active compounds with sig-
nificant structural modifications compared to learning set molecules, which also
distinguishes the ECP approach from QSAR-type methodologies.
4 Integration of Virtual and High-Throughput
Screening
Virtual and high-throughput screening are complementary in nature (Bajorath,
2002; Parker and Bajorath, 2006). Bleicher et al. (2003) argue that an iterative
approach which combines HTS and VS strategies is superior to an individual HTS
or VS setting where large compound libraries are screened without guidance or
feedback from intermediate steps. Each step in an iterative approach provides
rapid feedback and new information for the following step. In this way, computa-
tional and experimental resources can be adapted and focused on promising parts
of the chemical space, resulting in close cooperation of computational scientists
and chemists or biologists.
A formal framework integrating VS and HTS methods is provided by so-called
“iterative” or “sequential” screening1 schemes (Engels and Venkatarangan, 2001;
Parker and Bajorath, 2006), briefly illustrated in figure 4.1. The underlying idea
is to enrich small database subsets with novel hits and establish an iterative com-
putational and experimental screening protocol. Sequential screening integrates
VS and HTS methods by alternating iterations of computational VS and exper-
imental HTS applications. The first iteration starts with generating a computa-
tional model from known active compounds. As VS templates, already known
experimental hits are used or, alternatively, sets of known active compounds from
patents or the literature. Depending on the available data, VS methods such as
cluster analysis, QSAR, partitioning or similarity searching are then applied to
preselect small subsets from large compound libraries for experimental evaluation.
The subsets are experimentally screened and newly identified hits (or inactives)
are taken into account as additional information for model refinement during sub-
sequent rounds until a sufficiently large number of additional hits are obtained or
a maximum number of experimental evaluations is reached (Bajorath, 2002).
Combining VS and HTS in sequential screening can dramatically reduce the
number of compounds that need to be tested. Engels and Venkatarangan (2001)
compare the results of several sequential screening campaigns. They suggest that
1The term “sequential screening” will be used exclusively in the following.
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Figure 4.1: Illustration of sequential screening. Sequential screening starts with building
a computational model from known active compounds. This model is then used to
virtually screen a compound database to select compounds for experimental evaluation.
In this example, the first similarity search finds one active compound (green) and one
false-positive. In subsequent iterations, the newly discovered compounds are added to
the template set and used to refine the computational model. In this way, knowledge
derived from false-positive can also be included into the model-building step.
at least 50% of hits available in screening libraries can be identified by experimen-
tal testing of only 10–20% of all database compounds. Jones-Hertoz et al. (1999)
used recursive partitioning and a structure-based similarity search to screen a
compound collection for 14 G-protein–coupled receptors in a prospective study.
Both methods are based on binary descriptors encoding structural features. They
conclude that sequential screening provides a significant improvement over ran-
dom selection for testing, leading to a significant reduction in HTS costs.
This chapter presents two experiment that show the potential of the integrated
sequential screening scheme using an embedded ECP-based ranking or classifica-
tion method. The first experiment is based on the generally good performance
of ECP classifiers constructed on very small training sets. As described in sec-
tion 3.2, ECP-based classifiers could be trained on very small training sets where
other established methods failed. This motivated the design of an experiment
simulating early stages of lead-optimization processes where the objective is to
optimize sets of related compounds for activity against a given target. The exper-
iment uses randomly selected sets of compounds, e.g. from a combinatorial library
design project, to train ECP-based classifiers and to eliminate compounds with
low potency in an iterative manner. The second experiment shows how ECP-
based classification could be used as a ranking tool for similarity searching and
simulates a sequential screening experiment using a real HTS data set.
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4.1 Simulated Lead Optimization
Many drug discovery programs start with small sets of known active compounds,
e.g. results from HTS campaigns, known templates from literature or patent
sources. From these sets, libraries of analogues are produced which are then
tested experimentally for their activity. Here, a computational method was used
to guide compound selection and minimize the resources needed to produce a
small set of potent compounds. Instead of experimentally testing a large number
of analogues in a brute-force approach, the set is optimized in an iterative man-
ner integrating computational and experimental efforts illustrated in figure 4.2.
The idea is to start with a small random set of active compounds, e.g. HTS hits.
This small set is then divided into highly and weakly potent compounds using
the median potency as a threshold, and an ECP classifier is trained on this set
to distinguish between the two classes. The ECP classifier is then used to remove
weakly potent compounds from the remaining library, resulting in a reduced set
of hopefully more potent compounds. The procedure is repeated on the reduced
library for ten iterations to produce a small set of highly potent compounds.
Figure 4.3 shows the results for the four classes used in the ECP classification
evaluation described in section 3.2. For each activity class and training set size, the
calculations consistently reached convergence during the first eight or fewer iter-
ations, producing selection sets of less than 10 compounds with average potency
in the sub-micromolar range. Training sets of five or 10 compounds produced
comparable results. During the first few iterations a sharp decline in compound
numbers was observed for all classes accompanied by significant reduction in aver-
age IC50. Observed potency enrichment ranged from one (GSK3) to three orders
of magnitude (HIVPROT). For comparison, the same lead optimization simula-
tion procedure was implemented for DT and BIN as classification technique, and
the results are presented in appendix B. The observed potency enrichment sig-
nificantly differed from ECP. As expected, the DT classifier could not be used in
a meaningful way for only five training compounds because it classified the en-
tire test set to belong to one class, either eliminating all compounds, if classified
as weakly potent molecules, or retaining all compounds for the next iteration, if
classified as highly potent ones. Compared to BIN, ECP produced much better
potency enrichments on all classes by at least one order of magnitude for classes
HIVPROT and GSK3. For these classes, binary QSAR calculations failed to pro-
duce a median potency value below 1µM. On training sets with 10 compounds,
ECP also performed better than the other methods. Only for GSK3, the decision
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Figure 4.2: Three iterations of the simulated lead optimization process. In each iteration,
a small random subset from the compound library (top) is selected and evaluated. The
compound set is divided into two parts based on the median potency (dashed line).
All selected compounds are used as a training set to train an ECP classifier which
then removes all compounds from the library classified as weakly active. In the first
iteration (green), three compounds are selected for training. These three compounds
are used to train an ECP classifier which distinguishes highly potent (potency above
the median) from weakly active compounds, removing one compounds from the library.
In the second iteration (yellow), one compound is randomly selected and added to the
training set. The training set is split in two parts and four compounds (yellow) classified
as weakly active are removed. The final iteration adds one compound to the training
set which turns out to be highly active. Finally, six compounds (red) are removed from
the library and a set of four untested compounds remains.
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tree classifier achieved a potency enrichment close to ECP. For HIVPROT, only
ECP produced potencies below 1µM, with a sharp increase in average potency
from the third iteration on.
The iterative classification scheme devised for ECP led to significant enrichment
of potent compounds in small selection sets, without the need for careful training
set assembly. This approach should have considerable potential for the analysis of
analogue or target-focused libraries (Schnur et al., 2004) that can be enumerated
in-silico using different design protocols (Rose and Stevens, 2003) and the selection
of preferred subsets or single molecules. Precomputed libraries focused on known
active compounds can be subjected to iterative ECP classification in order to
identify library subsets enriched with compounds predicted to be most potent.
4.2 Simulated Sequential Screening
Having demonstrated the potential of integrating computational ECP-based VS
methods and experimental screening, it is straightforward to implement the full
sequential screening protocol using ECP-based VS. To do so, the binary classifi-
cation method must be transformed into a ranking method that is able to select
promising compounds from large library. This section describes this transforma-
tion and an evaluation of the protocol in a simulated sequential screening experi-
ment. The availability of real HTS data sets enables the design of studies which
mimic prospective studies instead of doing retrospective benchmarking on data
sets. The experimental HTS step of sequential screening can be simulated and thus
the experiment is more reliable than using an artificially constructed benchmark
set combining known active compounds with database compounds with unknown
activity. The analysis of real HTS data has two additional intrinsic advantages.
First, HTS data are generally prone to noise and experimental errors (Parker and
Bajorath, 2006), which is not the case in the standard VS benchmark scenario.
For example, the DHFR data set used in the experiment has been screened two
times, and the number of detected inhibitors has been corrected from 62 to 32.
Since these errors are an intrinsic problem of HTS methods, an experiment simu-
lating HTS steps as an integrated part of a sequential screening campaign should
also use error-prone HTS data. The second benefit is the experimental validation
of the whole screening database. Database compounds are commonly regarded as
inactive decoys in VS benchmarks, although large compound databases are very
likely to contain compounds active against the given target. Using HTS data
makes it possible to use experimentally validated inactives for training and evalu-
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Figure 4.3: Simulated lead optimization trials. Average potencies of the compound set
(left) and compound numbers (right) over 500 calculations of 10 iterations each are
reported for training sets of five and 10 compounds. Potencies and compound set sizes
show a rapid development to small nano-molar compound sets.
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Figure 4.3: continued.
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ation. All these aspects make simulations on HTS data more similar to practical
screening applications.
4.2.1 Screening Calculations
Data Set The design of the simulated sequential screening experiment differs
from the usual virtual screening benchmark scenario in several ways. First, se-
quential screening is concerned with the reduction of experimental efforts opposed
to maximizing recovery and hit rates, which is the scenario in VS benchmarks.
Because the experiment simulates the integration of computational VS and ex-
perimental HTS methods, it is important to simulate the experimental HTS step.
Typical VS experiments are constructed from databases as decoys and utilize opti-
mized literature compounds or even known drugs as potential hits. This approach
has two drawbacks for simulated sequential screening. Literature hits are usually
optimized with respect to pharmacological, biological, physicochemical and other
properties and differ substantially from non-optimized screening hits obtained in
typical HTS campaigns. Keseru¨ and Makara (2006) estimate the similarity of HTS
hit and lead compounds to only 0.61 based on MACCS keys and the Tanimoto
similarity coefficient2, indicating a rather low similarity for hits and leads. This
increases the gap between VS benchmarks and HTS experiments. As the goal of
this experiment is to simulate a sequential screening campaign, it is important
to use a data set of real screening hits as active compounds instead of literature
leads. To overcome these problems, the simulated sequential screening experiment
is based on a real HTS data set consisting of 50,000 test compounds produced
in the search for novel inhibitors against the well-known enzyme and drug target
dihydrofolate reductase (DHFR) (Zolli-Juran et al., 2003). DHFR catalyzes the
reduction of dihydrofolate to tetrahydrofolate. Inhibitors of this step are widely
used as anti-infective, anti-neoplastic and anti-inflammatory drugs (Schweitzer
et al., 1990), including wll-known examples such as methotrexate. DHFR is one
of the best studied therapeutical targets and has been an active area of research
for more than fifty years (Hitchings, 1989). Still, the development of new DHFR
inhibitors continues. DHFR inhibitor development is driven by drug resistances,
e.g. in tumors and malaria and the need for optimized target selectivity. Among
the 50,000 compounds there were a total of 32 confirmed competitive DHFR
2The MACCS keyed fingerprint is a structural fingerprint representation of molecules consisting
of 166 substructures. Each key is assigned one bit in a binary vector (fingerprint). Similarity
between two molecules is then computed as the similarity between two fingerprints, given
by the Tanimoto coefficient tc(A,B) = A·B‖A‖2+‖B‖2−A·B using the inner product between two
vectors. The Tanimoto coefficient measures the overlap of set bits.
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Figure 4.4: Structures of the 12 most active DHFR inhibitors. The comparison reveals
the presence of different scaffold types among the HTS hits.
inhibitors with Ki values3 ranging from 26 nM to 1µM (Elowe et al., 2005; Zolli-
Juran et al., 2003). This data set was made publicly available in the context of
the first McMaster University data mining and docking competition as a training
data set (Parker, 2005). Figure 4.4 shows the 12 most active inhibitors that were
identified in this screen, and the structures of all inhibitors are shown in figure C.1
in appendix C. As can be seen, these compounds have diverse structures. Most of
the highly active compounds shown in figure 4.4 contain a pyrimidine fragment,
which is a common theme for DHFR inhibitors. From the twelve most active
compounds, five (compounds 3,4,6,7 and 10) contain a quinazoline ring struc-
ture and resemble the structure of trimetrexate, an approved inhibitor of DHFR
used in the treatment of pneumonia. Compound 2 is trimethoprim, an antibiotic
3Ki is the inhibition constant of an active compound. It gives the concentration of a ligand
in a competition assay that would bind to 50% of the receptors if no competing radio-ligand
were present.
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drug used to treat urinary infections. The remaining active compounds are struc-
turally diverse, including a set of seven compounds based on a methylurea linker
fragment combining a 2-nitrothiophene ring with different aromatic rings. Some
of the inhibitors are small fused ring systems of one aromatic heterocycle, often
pyrimidine, and an unsaturated cyclohexane. Overall, the inhibitor set consists
of diverse structures with different chemotypes.
Methodology The simulated sequential screening experiment uses the set of 61
uncorrelated, information-rich descriptors described in section 2.1.1. The con-
tinuous descriptors are transformed into discrete attributes by a simple discret-
ization scheme. On small training sets, it is not possible to use the supervised
information-entropy based discretization method since this method would elimi-
nate most if not all of the descriptors. However, Eckert and Bajorath (2006) have
shown that descriptor value distributions are class-selective with the majority of
descriptor values found in small class-specific value ranges. These value ranges
are particularly attractive for the generation of patterns. The discretization pro-
cedure utilizes the value distribution in the training set by using the mean µ and
the standard deviation σ of each descriptor. Each descriptor is discretized into
three bins based on the mean value: (µ− σ, µ+ σ), (−∞, µ− σ] and [µ+ σ,∞).
Descriptors which show no variation at all or a high variation are removed before
discretization based on the coefficient of correlation cv = σµ . Descriptors without
variance limit the generalization of the classifier, whereas descriptors with a coeffi-
cient of variation cv > 1.0 are likely to have many irrelevant database compounds
populate the activity-class specific range around the mean, which severely restricts
the predictive value of such descriptors. Consequently, they are also omitted.
The sequential screening experiment goes beyond the binary ECP classification
experiment described in the previous chapter. Even though ECP classification
showed very high accuracy for active and inactive molecules, the uneven distribu-
tion of 32 active compounds and ∼50.000 inactive compounds induces high abso-
lute false-positive rates, making binary classification problematic or even useless
for virtual screening. To solve this problem, a ranking scheme is introduced which
ranks compounds based on their accumulated support on both classes. Each com-
pound is assigned a score which is computed by dividing the accumulated support
for being active by the accumulated support for being inactive. After ranking the
complete compound library, a small subset of the highest ranked compounds is
selected for simulated HTS screening.
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The simulated sequential screening experiment was done using the above de-
scribed methods to implement the sequential screening protocol. Initially, ECP
training was carried out on sets of five randomly selected DHFR inhibitors and
20 inactive compounds taken from the HTS data. Compounds were randomly
selected using a random number generator such that individual runs were inde-
pendent. The resulting ECP classifiers were then applied to rank all remaining
compounds in the remaining HTS data set. Following the sequential screening
paradigm, the top-scoring 10, 100, or 500 compounds are selected from the HTS
set and examined for new hits, thereby mimicking experimental evaluation of the
top-ranked compounds. From each selection set, the top-ranked 10 compounds
plus all remaining hits (for selection sets of 100 and 500 molecules) were then
added to the training set in order to re-build and refine the classifier for the next
iteration. For each selection set size (10, 100, or 500 molecules), 100 individual
trials using different training sets were carried out in order to produce a statisti-
cally relevant sample. In each case, a total of nine sequential screening iterations
were carried out such that the maximum number of “tested” compounds was
smaller than 10% of the entire HTS data set for the largest selection set of 500
compounds.
The experiment provides an interesting and challenging scenario to investigate
whether ECP calculations are sufficiently sensitive to select the very small number
of active molecules from a large number of inactive database compounds. Each
run of the sequential screening protocol starts with only five active compounds, a
number too small for typical classification procedures used in virtual compound
screening. Since the HTS set contains 32 actives out of 50.000 compounds, the
database contains only 27 possible hits.
For each selection set size, 100 independent calculations with different training
sets are evaluated in order to (a) determine the top performance and potential
of the ECP methodology and (b) estimate the expected performance level in
iterative screening independent of the composition of learning sets. This was
done because compound classification calculations are generally much influenced
by compound-class specific features and training set composition (Bajorath, 2002;
Parker and Bajorath, 2006). For ECP, this analysis was particularly relevant since
only five active compounds were used for training, which put high weight on the
characteristics and contributions of each individual molecule. The experiment
provides a good test of the ability of the ECP classifier to generalize from a very
small set of training samples.
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The remaining part of this section presents the results of the simulated sequen-
tial screening calculations by analyzing statistical and qualitative features of the
computed patterns and by evaluating the performance of the screening protocol
in terms of recovery rates. Special attention is paid to the dynamic interaction
between computational and (simulated) screening methods.
4.2.2 Pattern Distribution and Composition
The quality of the ECP classifier relies on its ability to derive discriminating
patterns from the training data. These patterns must reflect the properties of
the training data, but also be general enough for prediction of unknown test
compounds. The composition of the patterns is also interesting from a knowledge
mining point of view. Knowledge about the used descriptors, including their num-
ber, type, complexity and about the pattern size and distribution are of significant
interest.
A quantitative analysis of the pattern composition was done based on the sim-
ulated sequential screening protocol described above. On average, 29 to 30 (of
61 available) descriptors were utilized in each ECP calculation, thus only about
half the descriptor basis set. Therefore, large numbers of descriptors were not
required for pattern derivation. For active compounds in the learning set, on av-
erage ∼10,700 patterns consisting of 7.5 descriptor value pairs were produced. By
contrast, for inactive compounds on average only ∼170 patterns emerged with 3.3
descriptor value pairs per pattern. Thus, active compounds generated significantly
more and larger patterns than inactive ones. These findings can be rationalized
by considering that during learning each active compound must be distinguished
from all inactive molecules and vice a versa. Since there were considerably more
inactive than active compounds in each training set, active molecules required
more descriptors to be distinguished from inactive compounds. Therefore, the
large difference in the number of patterns between active and inactive molecules
is due to the fact that the number of potential patterns grows exponentially in
descriptor spaces of increasing dimensionality. It follows that the deliberately un-
balanced composition of the learning sets was reflected in large differences in the
numbers of “active” and “inactive” patterns, consistent with expectations. For
iterative screening applications, learning sets should contain more inactive than
active compounds because many more inactive molecules are available.
Given the large amount of computed patterns, an in depth analysis of the pat-
tern composition is a demanding task. For the sake of simplicity, the analysis is
limited to the discretization step of the simulated sequential screening protocol.
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Figure 4.5: Descriptors used in more than 50% of the simulated sequential screening
iterations. For each descriptor, the percentage of all iterations it has been used in
(blue) and the percentage of all iterations where it has been removed due to a large
coefficient of variation (red) or because of no variation (yellow) is shown. The first 15
descriptors are used in all iterations and merged into a single bar.
The discretization procedure removes descriptors with no variation and descrip-
tors with a high coefficient of variation. Figure 4.5 shows the statistics for the 30
descriptors which are used in at least 50% of all iterations. The analysis shows that
12 out of 30 prominent descriptors are rather simple atom/bond counts, pharma-
cophore properties or adjacency measures. These descriptors are pure 2D (type II)
descriptors. Two estimated physical property descriptors (TPSA and logP(o/w))
are included in almost every iteration. Most of the more complicated implicit 3D
descriptors are removed in most iterations, with notably exceptions of descriptors
relating to partial charge (PEOE VSA +0, PEOE RPC-, PEOE VSA FNEG).
The importance of molecular refractivity and the octanol/water partitioning coef-
ficient is further emphasized by the prominence of implicit 3D descriptors relating
to atomic contributions to these properties.
4.2.3 Screening Performance
The global analysis statistically estimates the performance of ECP simulated se-
quential screening based on 100 independent trials. Since each trial is based on
different, randomly sampled selection sets, learning sets which result in classifiers
with different performance in the first iterations are taken into account. In some
cases, the initial classifier fails to find any active compounds, but improves by
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adding more information about inactive compounds in subsequent runs. The re-
sults are reported in figure 4.6 and table 4.1. Figure 4.6 summarizes the recovery
rate of 100 trials with selection set size of 10, 100 and 500 compounds. Table 4.1
additionally shows the training set size, number of virtually tested compounds
and the absolute number of found active compounds. For selection sets of 10,
100, and 500 database compounds, average recovery rates of 19%, 26%, and 39%
were observed, respectively. For the smallest selection set, this corresponds to
the identification of approximately five hits when evaluating only 115 database
compounds (∼0.2% of the HTS set) and for the largest selection set, 10 to 11 hits
based on the evaluation a total of 4525 compounds (∼9%). In terms of enrichment
factors, the experiments with selection set size 10 resulted in an enrichment of 83.7
compared to random selection of 115 compounds from the complete screening set.
The enrichment factors for the other two experiments decreased with the number
of virtually tested compounds. For selection sets of size 100, the experiments es-
timated a 14-fold enrichment over random selection, and for the largest selection
set size of 500, only a 4.3-fold enrichment was observed.
The steady increase in average recovery rates over the nine iterations indicated
that additional hits could be retrieved by adding more screening cycles. An at-
tractive feature of iterative ECP calculations was the enrichment of hits among
selection sets of only 10 compounds, where evaluation of 115 database compounds
was sufficient to produce on average five hits, given initial learning sets containing
only five active compounds. The high enrichment in these experiments and the
small number of evaluations during each iteration render this setting an attractive
candidate for extending the number of iterations. On average, selecting 10 times
more database compounds gave two additional hits and testing 50 times more
compounds doubled the number of recovered hits relative to the smallest selec-
tion sets. These results were well in accord with the previous findings that ECP
was capable of successfully operating on the basis of very few active compounds
and revealed an additional aspect, the presence of high sensitivity and specificity
of ECP calculations, especially for small compound selection sets: most of the
recovered active compounds are highly active. Investigating the recovery of the
subset of the 12 most potent hits in the DHFR HTS set shown in figure 4.4 re-
vealed that the final iteration for selection sets of 10, 100, and 500 compounds
contained on averaged about four, five or six of these hits, respectively, showing
a clear tendency to select highly active compounds from the screening data set.
Thus, in small selection sets, the largest relative enrichment of potent hits was
observed. Taken together, these findings indicate that ECP simulated sequen-
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Figure 4.6: Average recovery rates over 100 independent screening trials.
Table 4.1: Average ECP results over 100 independent screening trials. Averages are
reported for all nine iterations and selection sets of 10, 100, and 500 database com-
pounds. The total number of tested database compounds (“TS”) is given and “RR”
provides averaged cumulative recovery rates. Averages are reported for all nine itera-
tions and selection sets of 10, 100, and 500 database compounds. Column “It.” counts
the iteration, TS states the size of the test set in each iteration, “TR” the training set
size, “ACT” the number of found actives and RR[%] the recovery rate of found actives
in percent.
10 100 500
It. TS TR ACT RR[%] TS TR ACT RR[%] TS TR ACT RR[%]
1 35 35 1.32 4.9 125 36.00 2.41 8.9 525 37.40 3.94 14.6
2 45 45 1.78 6.6 225 46.84 3.78 14.0 1025 49.09 6.29 23.3
3 55 55 2.73 10.1 325 57.26 4.69 17.4 1525 60.01 7.47 27.7
4 65 65 3.53 13.1 425 67.74 5.41 20.0 2025 70.61 8.26 30.6
5 75 75 4.00 14.8 525 78.00 5.80 21.3 2525 81.24 8.94 33.1
6 85 85 4.50 16.6 625 89.00 6.40 23.7 3025 91.80 9.52 35.3
7 95 95 4.90 18.2 725 99.00 6.60 24.6 3525 102.15 9.95 36.9
8 105 105 5.10 18.9 825 109.00 6.90 25.6 4025 112.40 10.20 37.8
9 115 115 5.20 19.4 925 119.00 7.10 26.3 4525 122.71 10.60 39.1
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Figure 4.7: Hit rate for three simulated sequential screening trials using a selection set
of 10 compounds. Each color indicates one independent trial, with dark segments in
each bar showing the number of found active compounds. ECP virtual screening fails
to select active compounds in the first three iterations of trial three. However, the
iteratively refined classifier finds active compounds in subsequent iterations.
tial screening produced recovery rates that were at least comparable to expected
results of 40% recovery while testing approximately 10% of the database (En-
gels and Venkatarangan, 2001) when clustering or other classification methods
were used for sequential screening. However, ECP calculations already recovered
approximately 20% of available hits when only about 100 of 50,000 screening
set compounds were evaluated, and these hits were among the most potent ones
available in the HTS set. Therefore, the application of ECP is thought to further
reduce compound selection set sizes in iterative screening trials, which adds to the
sequential screening paradigm.
Selection set size influenced the calculations because different numbers of ac-
tive molecules were added to the training sets during each of the nine iterations.
Selection sets of increasing size, from 10 to 100 and 500 compounds, typically
contained an increasing number of hits that were added to the training set for the
next iteration. The more active compounds are available, the better the basis for
training becomes.
4.2.4 Dynamic Interaction of VS and HTS
The dynamic interaction between computational virtual screening and experimen-
tal screening methods cannot be investigated in a global statistical analysis of the
screening performance of simulated sequential screening. In order to investigate
if and how the ECP classifier benefits from the feedback provided by the sim-
ulated HTS experiments, individual runs of the simulated sequential screening
experiment were analyzed. Tables 4.2 to 4.4 report the top ten ECP trials for
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Table 4.2: Top 10 ECP trials for selection sets of 10 database compounds. “TR” reports
the size of the training sets, “ACT” reports the total number of active compounds
retrieved (with newly identified ones added to the training set for the next round), and
“RR” reports the cumulative recovery rates of active compounds.
Trial
Iteration 1 2 3 4 5 6 7 8 9 10
1
TR 35 35 35 35 35 35 35 35 35 35
ACT 3 3 3 3 3 3 3 3 3 3
RR[%] 11.1 11.1 11.1 11.1 11.1 11.1 11.1 11.1 11.1 11.1
2
TR 45 45 45 45 45 45 45 45 45 45
ACT 5 5 5 5 5 5 5 5 5 5
RR[%] 18.5 18.5 18.5 18.5 18.5 18.5 18.5 18.5 18.5 18.5
3
TR 55 55 55 55 55 55 55 55 55 55
ACT 5 5 5 5 5 5 5 5 5 5
RR[%] 18.5 18.5 18.5 18.5 18.5 18.5 18.5 18.5 18.5 18.5
4
TR 65 65 65 65 65 65 65 65 65 65
ACT 7 7 7 7 7 7 7 7 7 7
RR[%] 25.9 25.9 25.9 25.9 25.9 25.9 25.9 25.9 25.9 25.9
5
TR 75 75 75 75 75 75 75 75 75 75
ACT 7 7 7 7 7 7 7 7 7 7
RR[%] 25.9 25.9 25.9 25.9 25.9 25.9 25.9 25.9 25.9 25.9
6
TR 85 85 85 85 85 85 85 85 85 85
ACT 7 7 7 7 7 7 7 7 7 7
RR[%] 25.9 25.9 25.9 25.9 25.9 25.9 25.9 25.9 25.9 25.9
7
TR 95 95 95 95 95 95 95 95 95 95
ACT 8 8 8 8 8 8 8 8 8 8
RR[%] 29.6 29.6 29.6 29.6 29.6 29.6 29.6 29.6 29.6 29.6
8
TR 105 105 105 105 105 105 105 105 105 105
ACT 9 9 9 9 9 9 9 9 9 9
RR[%] 33.3 33.3 33.3 33.3 33.3 33.3 33.3 33.3 33.3 33.3
9
TR 115 115 115 115 115 115 115 115 115 115
ACT 9 9 9 9 9 9 9 9 9 9
RR[%] 33.3 33.3 33.3 33.3 33.3 33.3 33.3 33.3 33.3 33.3
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Table 4.3: Top 10 ECP trials for selection sets of 100 database compounds. “TR” reports
the size of the training sets, “ACT” reports the total number of active compounds
retrieved (with newly identified ones added to the training set for the next round), and
“RR” reports the cumulative recovery rates of active compounds.
Trial
Iteration 1 2 3 4 5 6 7 8 9 10
1
TR 36 36 35 35 35 35 35 36 36 38
ACT 4 4 0 0 0 0 0 3 3 4
RR[%] 14.8 14.8 0.0 0.0 0.0 0.0 0.0 11.1 11.1 22.2
2
TR 49 48 45 45 45 45 45 47 46 49
ACT 8 7 0 0 0 0 0 10 4 7
RR[%] 29.6 25.9 0.0 0.0 0.0 0.0 0.0 37.0 14.8 25.9
3
TR 62 58 56 56 56 56 56 57 56 59
ACT 13 7 1 1 1 1 1 10 4 8
RR[%] 48.1 25.9 3.7 3.7 3.7 3.7 3.7 37.0 14.8 29.6
4
TR 72 70 68 68 68 68 68 68 66 69
ACT 13 11 4 4 4 4 4 11 4 8
RR[%] 48.1 40.7 14.8 14.8 14.8 14.8 14.8 40.7 14.8 29.6
5
TR 83 80 79 79 79 79 79 78 77 79
ACT 14 11 5 5 5 5 5 11 5 8
RR[%] 51.9 40.7 18.5 18.5 18.5 18.5 18.5 40.7 18.5 29.6
6
TR 93 90 91 91 91 91 91 88 88 90
ACT 14 11 8 8 8 8 8 11 7 9
RR[%] 51.9 40.7 29.6 29.6 29.6 29.6 29.6 40.7 25.9 33.3
7
TR 103 101 106 102 102 102 102 98 99 101
ACT 14 12 9 9 9 9 9 11 8 10
RR[%] 51.9 44.4 33.3 33.3 33.3 33.3 33.3 40.7 29.6 37.0
8
TR 113 111 117 113 113 113 113 108 111 112
ACT 14 12 10 10 10 10 10 11 11 11
RR[%] 51.9 44.4 37.0 37.0 37.0 37.3 37.0 40.7 40.7 40.7
9
TR 123 121 128 124 124 124 124 118 121 122
ACT 14 12 11 11 11 11 11 11 11 11
RR[%] 51.9 44.4 40.7 40.7 40.7 40.7 40.7 40.7 40.7 40.7
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Table 4.4: Top 10 ECP trials for selection sets of 500 database compounds. “TR” reports
the size of the training sets, “ACT” reports the total number of active compounds
retrieved (with newly identified ones added to the training set for the next round), and
“RR” reports the cumulative recovery rates of active compounds.
Trial
Iteration 1 2 3 4 5 6 7 8 9 10
1
TR 39 38 39 37 38 41 43 41 36 41
ACT 5 6 6 3 5 8 8 6 7 9
RR[%] 18.5 22.2 22.2 11.1 18.5 29.6 29.6 22.2 25.9 33.3
2
TR 52 48 51 51 51 53 55 55 47 53
ACT 9 6 9 10 8 10 10 11 9 11
RR[%] 33.3 22.2 33.3 37.0 29.6 37.0 37.0 40.7 33.3 40.7
3
TR 62 58 62 64 64 64 68 65 57 64
ACT 9 6 10 13 11 14 13 11 9 12
RR[%] 33.3 2.2 37.0 48.1 40.7 51.9 48.1 40.7 33.3 44.4
4
TR 75 69 72 74 78 75 78 76 68 74
ACT 12 7 10 13 15 15 13 12 10 13
RR[%] 44.4 25.9 37.0 48.1 55.6 55.6 48.1 44.4 37.0 48.1
5
TR 90 80 84 85 88 85 90 86 82 84
ACT 17 8 13 14 15 15 15 12 14 13
RR[%] 63.0 29.6 48.1 51.9 55.6 55.6 55.6 44.4 51.9 48.1
6
TR 101 93 96 96 99 95 100 98 93 94
ACT 18 11 15 15 16 15 15 14 15 13
RR[%] 66.7 40.7 55.6 55.6 59.3 55.6 55.6 51.9 55.6 48.1
7
TR 111 105 106 107 109 106 110 109 103 105
ACT 18 13 15 16 16 16 15 15 15 14
RR[%] 66.7 48.1 55.6 59.3 59.3 59.3 55.6 55.6 55.6 51.9
8
TR 121 117 117 117 119 116 120 119 113 115
ACT 18 16 16 16 16 16 15 15 15 14
RR[%] 66.7 59.3 59.3 59.3 59.3 59.3 55.6 55.6 55.6 51.9
9
TR 132 128 128 127 129 126 130 129 123 126
ACT 19 18 17 16 16 16 15 15 15 15
RR[%] 70.4 66.7 63.0 59.3 59.3 59.3 55.6 55.6 55.6 55.6
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selection sets of 10, 100, and 500 compounds, respectively. The results reflect the
trends of the global performance analysis. For selection sets of only 10 database
compounds, the best individual trials recovered 33% of the hits (table 4.2), which
corresponded to nine of 27 available active compounds. The top ten trials showed
the same retrieval characteristics because they identified the same sets of active
compounds, despite different learning set composition (whereas other trials within
the top 20 list produced different sets). During iterative screening, the number of
cumulatively identified hits increased from three in the first trial to nine after the
last. For selection sets of 100 compounds (table 4.3), the best cumulative recovery
rate of individual trials was 52% corresponding to 14 of 27 hits. Here retrieval
characteristics substantially differed and in some instances, individual trials pro-
duced good results, although active compounds could not be recovered during the
first one or two iterations, as illustrated by the third experiment shown in fig-
ure 4.7. In these cases, the training sets were expanded by addition of 10 inactive
compounds per iteration, which then led to the identification of hits. Adding the
top-ten compounds even if they are misclassified inactives gives additional infor-
mation to the training phase of the next ECP classifier, which can then use this
information to generate patterns that became increasingly characteristic for active
compounds because more inactive molecules needed to be discriminated. This
dynamic interaction between computational and simulated experimental meth-
ods highlights the benefits of the integration of both methods in the sequential
screening paradigm. These findings further illustrate the usefulness of unbalanced
training sets if only a few hits were available for learning and because inactive
compounds contain information for ECP classification. Unbalanced training sets
(and test sets) pose serious problems to classification algorithms, but in this case,
classification actually benefits from the introduced bias. Extending the training
set for inactive compounds makes the ECP classifier more specific for the subtle
differences in the descriptor value distribution and thus lowers the probability of
matched patterns for inactive compounds.
Best recovery rates were obtained for selection sets of 500 compounds, as ex-
pected (table 4.4). Here the top ten trials retrieved between 15 and 19 hits,
producing a top recovery rate of 70%. Thus, at top performance levels, iterative
ECP calculations were capable of producing significant retrieval rates for selection
sets of varying size.
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4.3 Discussion
The integration of VS and HTS methods is explored in this chapter. ECP-based
computational classification and ranking methods were used in two experiments to
evaluate if and how iterative screening protocols could be used in drug discovery
programs. First, binary ECP classifiers were used to optimize sets of known
active compounds, a common topic in early stages of drug discovery programs,
e.g. when optimizing HTS hits. It could be shown that ECP classification generally
optimizes QSAR data sets of several hundred compounds with different activity
distributions into small highly potent sets within a few iterations of alternating
computational classification and simulated experimental screening. Compared to
decision trees and binary QSAR, only ECP could be used reliably in this situation
where the number of known actives was extremely small.
The simulated lead optimization experiment has shown the potential of sequen-
tial screening protocols. However, this study is based on binary classification and
uses QSAR benchmark data sets instead of real HTS data. Consequently, the
next step was to extend ECP classification into a ranking method for prioritizing
compounds with respect to activity and design a sequential screening experiment.
The publicly available DHFR screening data set made it possible to simulate
the outcome of HTS screens and to perform a thorough statistical analysis of
the methodology in simulated sequential screening demonstrating the potential of
modern data mining techniques in pharmaceutical research. Although this screen-
ing paradigm is currently far from being established in pharmaceutical research,
it is increasingly considered a complement or an alternative to brute force HTS
(Bajorath, 2002; Engels and Venkatarangan, 2001; Parker and Bajorath, 2006).
In simulated sequential screening trials, ECP calculations generated a steady in-
crease in the recovery of active compounds and already produced multiple hits
by iteratively selecting as little as 0.2% of the HTS data set. The efficiency of
sequential screening strongly depends on the performance of the embedded virtual
screening method. It must be able to generalize from small sets of known active
(and inactive) compounds, fast enough to screen large compound collections and
also be sensitive to changes in the training data during the sequential screening
iterations. Each iteration provides the classifier with new knowledge and should
result in a refined model, possibly correcting previous errors. The need for a
sensitive method working on small training sets and the ubiquitous errors in ex-
perimental testing requires methods which generalize well from individual features
of the training set and provide high-resolution models. ECP has been shown to be
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easily implemented into sequential screening protocols and to yield high recovery
rates after a small number of iterations.
Clearly, with 50,000 compounds, the DHFR test set studied here was smaller
than many currently used HTS compound sets that are frequently an order of
magnitude larger. However, the size of screening sets is not a limiting factor for
ECP sequential screening and given the observed sensitivity and specificity of the
calculations, there are no reasons to expect substantially different results if vary-
ing screening set size. ECP calculations are particularly attractive for sequential
screening applications when complete recovery of available active compounds is
not the primary goal of the screening efforts, but rather rapid recovery of novel
hits. The results further support the view that iterative computational and ex-
perimental screening can streamline biological screening efforts and greatly reduce
the experimental and data analysis requirements, including secondary assays to
eliminate false-positives. If a practical ECP-supported sequential screening appli-
cation on the DHFR set would have produced results similar to our simulations,
it would have been possible to replace HTS analysis of this data set with series of
low-throughput assays to identify multiple hits. These findings suggest that ECP
analysis should merit further consideration in HTS data mining and sequential
screening.
5 Summary and Conclusion
This chapter summarizes the findings of this thesis regarding the three questions
presented in the introduction. First, emerging pattern (EP) mining has been
adapted to chemoinformatics by using discretized molecular descriptors as nominal
attributes. EPs based on these descriptors were formally defined as emerging
chemical patterns (ECP) in chapter 2. Using this methodology, knowledge mining
and property prediction capabilities of ECPs were explored in chapter 3. Finally,
the integration of computational and experimental methods is investigated by the
experiments presented in chapter 4. Chapter 3 answers questions one and two,
and chapter 4 provides a possible answer to the last question. These answers are
summarized in the remaining part of this section.
Question 1: How can pattern mining-based knowledge be
rationalized at the molecular level?
Section 3.1 has shown that ECPs are able to capture even subtle differences be-
tween bioactive binding and computationally generated energy-minimized confor-
mations. ECPs reflected well-known strain energy penalties on a global level. On
a per-class level, ECPs were able to find more detailed differences in the two con-
formation sets. For each of the 18 classes investigated, discriminating patterns
matching stringent support thresholds were computed. These patterns did not
only contain energy descriptors, but also descriptors that can be related directly
to differences in shape and surface properties.
Furthermore, these class-specific patterns could be rationalized on a molecu-
lar level. Binding conformations of protocatechuate-3,4-dioxygenase inhibitors
can be easily discriminated from computer-generated conformations by looking
at the extension along the third principle axis. A cation in the binding pocket
of protocatechuate-3,4-dioxygenase forces the substituents to move out of the
molecule’s main plane into an energetically unfavorable position. This change
is then reflected by the corresponding patterns. Additionally to this simple in-
terpretation, conformational changes of ligands can be related to changes in the
interaction network which is formed upon binding to the target protein. It could
be shown for three exemplary classes that discriminating patterns can be re-
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lated to important distortions in the binding conformations which are not found
in energy-minimized conformations due to energetic penalties. This presents a
strong advantage of the easy interpretation of ECPs and highlights their ability
to capture class-specific information in biological applications.
Question 2: How does a pattern-based classifier perform on
biological data?
ECP-based classifiers have been extensively evaluated on biological data. In sec-
tion 3.2, ECP-based classification was shown to be at least comparable to standard
binary classification methods for property prediction. Four different QSAR data
sets were used to evaluate the accuracy of ECP-based classification, decision tree
and binary QSAR property prediction methods. While all methods performed
equally well when predicting the potency level of individual compounds, only
ECP-based classification could be used on training sets as small as containing
only three compounds from each class. This is of outstanding significance for
early stages of pharmaceutical drug discovery processes where typically only a
few active compounds are at hand. A classifier with good predictive capabilities
in highly and weakly potent classes certainly is of great benefit in these early
stages, e.g. when designing focused libraries based on active HTS hits.
In chapter 4, ECP-based iterative experiments have been introduced which
further show the potential of pattern mining methods when processing biolog-
ical data. The experiments show how the binary classification scheme can be
extended to compound ranking. In pharmaceutical settings, early discovery of
active compounds is more important than complete recovery. The simulated se-
quential screening experiment shows that ECP-based ranking rapidly finds hidden
active compounds even in imbalanced data sets. Given the large size-difference in
available experimentally tested compounds and the size of current compound da-
tabases, it is very important that data mining algorithms used in chemoinformatic
campaigns can handle this biased data.
Question 3: Is it possible to integrate computational and ex-
perimental methods in an efficient way such that both meth-
ods benefit from the integration?
The complementary nature of computational (VS) and experimental (HTS) meth-
ods is explored in chapter 4. First, an iterative protocol was designed simulating
compound selection tasks common to lead optimization stages in drug discovery.
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This experiment iteratively combined ECP classification and (simulated) exper-
imental evaluation of a training set. Starting from a small set of known active
compounds, each of the four classes used in the classification evaluation in sec-
tion 3.2 was optimized to small sets of highly potent compounds. After training
an ECP classifier on the initial training set, all compounds predicted to be weakly
active were removed from the remaining set. A small number of the remaining
compounds was then added to the training set. It is shown that after a small
number of iterations, small compound sets with potency below 1µM could be
produced with ECP classifiers, but not with decision tree or binary QSAR meth-
ods.
In section 4.2 the potential of VS and HTS integration has been investigated. It
has been shown how the sequential screening paradigm can be implemented with
ECP-based compound ranking. The availability of real HTS data enabled the
design of an experiment which mimics real-world screening campaigns, but still
offers the opportunity to do statistically valid evaluations. Experiments which use
HTS data instead of artificially constructed benchmark data sets are more signif-
icant and closer to prospective studies. Typical benchmark data sets introduce a
structural bias for active compounds which is not the case for HTS data sets. In
addition to that, HTS experiments are generally error-prone and the simulation
of HTS by using a stored outcome for simulation also keeps this intrinsic error.
The analysis of the simulated sequential screening calculations has shown that
testing a small fraction of only 0.2% of the available compound library still rec-
ognizes 20% of the contained hits. It is very likely that the recovery rate will be
improved if the sequential screening calculations are extended for more than nine
iterations. This dramatic decrease in experimental effort while still keeping high
recognition of active hits is expected to be of great benefit for pharmaceutical
research.
Screening also benefits from the iterative nature of sequential screening pro-
tocols. Feedback provided by previous iterations enabled the ECP classifier to
correct errors made in earlier runs. In this way, the classifier was able to find a
high number of hits even when classification completely failed in earlier iterations.
In summary, the emerging pattern mining framework as introduced in the
data mining community by Dong et al. (1999b) has been successfully adapted
to chemoinformatic problems. Combining EP mining and the well-known notion
of chemical descriptors, emerging chemical patterns are defined as class-specific
descriptor-value range combinations. These combinations capture even subtle
82
differences in different compound sets and can be used for knowledge mining
compound data (section 3.1) or for property prediction as binary classifiers (sec-
tion 3.2). In a second part, the integration of ECP-based classification and HTS
methods is evaluated in the form of simulated sequential screening. Sequential
screening as described herein shows how both embedded methods can benefit
from each other and justifies a tight integration of the work computational and
experimental scientists in drug discovery projects.
A Chemical Descriptors
A.1 61 Uncorrelated Descriptors
Table A.1: 61 uncorrelated type I and II descriptors. Seven different types of descriptors
are used: (computed) physical properties, atom or bond counts, connectivty indices,
distance matrix measures, subdivided surface area properties and partial charge de-
scriptors. The van–der–Waals surface area (VDW surface area) vi for atom i is ap-
proximated from the connection table (Labute, 2004). For subdivided surface area
descriptors, Li denotes the contribution of atom i to the logP(octanol/water) parti-
tioning coefficient and Ri denotes the contribution of atom i to the molar refractivity
as described in Wildman and Crippen (1999). Partial charges are estimated by the
partial equalization of orbital electronegativities (PEOE) method from Gasteiger and
Marsili (1980).
Descriptor Type Definition
logP(o/w) phys. property Log of the octanol/water partition
coefficient (Labute, 1998)
TPSA phys. property Polar VDW surface area (connection
table approximation) (Ertl et al., 2000)
a ICM atom count Atom information content (mean)
a nBr atom count No. of bromine atoms
a nCl atom count No. of chlorine atoms
a nF atom count No. of fluorine atoms
a nI atom count No. of iodine atoms
a nN atom count No. of nitrogen atoms
a nO atom count No. of oxygen atoms
a nP atom count No. of phosphor atoms
a nS atom count No. of sulfur atoms
b 1rotR bond count Fraction of rotatable bonds
b 1rotN bond count No. of rotatble bonds
b double bond count No. of double bonds
b triple bond count No. of triple bonds
balabanJ distance matrix Balaban averaged distance sum
connectivity (Balaban, 1982)
petitjean distance matrix (diameter − radius)/diameter (Petitjean,
1992)
VDistEQ distance matrix Vertex distance equality index
83
A.1. 61 UNCORRELATED DESCRIPTORS 84
chi0v C connectivity index Carbon valence connectivity index of
order 0 (Hall and B.Kier, 1991; Hall and
Kier, 1977).
SlogP VSA0 subdiv. surf. area Σvi such that Li ≤ −0.40
SlogP VSA1 subdiv. surf. area Σvi such that Li ∈ (−0.40,−0.20]
SlogP VSA2 subdiv. surf. area Σvi such that Li ∈ (−0.20, 0.00]
SlogP VSA3 subdiv. surf. area Σvi such that Li ∈ (0.00, 0.10]
SlogP VSA4 subdiv. surf. area Σvi such that Li ∈ (0.10, 0.15]
SlogP VSA5 subdiv. surf. area Σvi such that Li ∈ (0.15, 0.20]
SlogP VSA7 subdiv. surf. area Σvi such that L ∈ (0.25, 0.30]
SlogP VSA8 subdiv. surf. area Σvi such that Li ∈ (0.30, 0.40]
SlogP VSA9 subdiv. surf. area Σvi such that Li > 0.40
SMR VSA0 subdiv. surf. area Σvi such that Ri ∈ (0.00, 0.11]
SMR VSA1 subdiv. surf. area Σvi such that Ri ∈ (0.11, 0.26]
SMR VSA2 subdiv. surf. area Σvi such that Ri ∈ (0.26, 0.35]
SMR VSA3 subdiv. surf. area Σvi such that Ri ∈ (0.35, 0.39]
SMR VSA4 subdiv. surf. area Σvi such that Ri ∈ (0.39, 0.44]
SMR VSA5 subdiv. surf. area Σvi such that Ri ∈ (0.44, 0.49]
SMR VSA6 subdiv. surf. area Σvi such that Ri ∈ (0.485, 0.56]
a acc pharmacophore No. of hydrogen bond acceptor atoms
a don pharmacophore No. of hydrogen bond acceptor atoms
a base pharmacophore No. of basic atoms
vsa acid pharmacophore VDW surface areas of acidic atoms
vsa base pharmacophore VDW surface areas of basic atoms
vsa don pharmacophore VDW surface areas of H-bond donors
vsa other pharmacophore VDW surface area of other atoms
vsa pol pharmacophore VDW surface areas of polar atoms
PEOE RPC- partial charge Relative negative partial charge
PEOE VSA FNEG partial charge Fractional negative VDW surface area
PEOE VSA FHYD partial charge Fractional hydrophobic VDW surface area
PEOE VSA+0 partial charge Σvi where qi ∈ [0.00, 0.05)
PEOE VSA+1 partial charge Σvi where qi ∈ [0.05, 0.10)
PEOE VSA+2 partial charge Σvi where qi ∈ [0.10, 0.15)
PEOE VSA+3 partial charge Σvi where qi ∈ [0.15, 0.20)
PEOE VSA+4 partial charge Σvi where qi ∈ [0.20, 0.25)
PEOE VSA+5 partial charge Σvi where qi ∈ [0.20, 0.30)
PEOE VSA+6 partial charge Σvi where qi ≥ 0.30
PEOE VSA-0 partial charge Σvi where qi ∈ [−0.05, 0.00)
PEOE VSA-1 partial charge Σvi where qi ∈ [−0.10,−0.05)
PEOE VSA-2 partial charge Σvi where qi ∈ [−0.15,−0.10)
PEOE VSA-3 partial charge Σvi where qi ∈ [−0.20,−0.15)
PEOE VSA-4 partial charge Σvi where qi ∈ [−0.25,−0.20)
PEOE VSA-5 partial charge Σvi where qi ∈ [−0.30,−0.25)
PEOE VSA-6 partial charge Σvi where qi < −0.30
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A.2 3D Descriptors for Conformation Anaylsis
Table A.2: The set of type III (3D) descriptors used for conformation difference mining.
The descriptors are calculated with MOE after normalization as described in 3.1.2.
For descriptors using the AM1 (Dewar et al., 1985), PM3 (Stewart, 1989) or MNDO
(Dewar and Thiel, 1977) method, MOE uses an integrated implementation of MOPAC
(Stewart, 1990). The descriptors are grouped into five different classes energy, shape,
charge, surface and volume depending on the chemical property they encode.
Descriptor Type Definition
E energy Potential energy
E ang energy Angle bending energy component of the potential energy
E ele energy Electrostatic energy component of the potential energy
E nb energy Non-bonded energy component of the potential energy
E oop energy Out-of-plane energy component of the potential energy
E sol energy Solvation energy component of the potential energy
E stb energy Bond stretching - angle bending energy component of the
potential energy
E str energy Bond stretch energy component of the potential energy
E strain energy Strain energy component of the potential energy
E tor energy Torsion energy component of the potential energy
E vdw energy Van der Waals energy component of the potential energy
AM1 E energy Potential energy calculated with the semi-empirical AM1
method
AM1 Eele energy AM1 electrostatic energy component
AM1 IP energy AM1 ionization potential
AM1 HF energy AM1 heat of formation
AM1 HOMO energy AM1 energy of the highest occupied molecular orbital
AM1 LUMO energy AM1 energy of the lowest unoccupied molecular orbital
PM3 E energy Potential energy calculated with the semi-empirical PM3
method
PM3 Eele energy PM3 electrostatic energy component
PM3 IP energy PM3 ionization potential
PM3 HF energy PM3 heat of formation
PM3 HOMO energy PM3 energy of the highest occupied molecular orbital
PM3 LUMO energy PM3 energy of the lowest unoccupied molecular orbital
MNDO E energy Potential energy calculated with the semi-empirical
modified neglect of diatomic overlap (MNDO)
MNDO Eele energy MNDO electrostatic energy
MNDO IP energy MNDO ionization potential
MNDO HF energy MNDO heat of formation
MNDO HOMO energy MNDO energy of the highest occupied molecular orbital
MNDO LUMO energy MNDO energy of the lowest unoccupied molecular orbital
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glob shape Globularity index. Fraction of the smallest and largest
Eigenvalue of the covariance matrix of atomic coordinates.
Values range from 0.0 (two- or onedimensional objects) to
1.0 (perfect sphere)
std dim1 shape Standard deviation of coordinates along the first principal
axis
std dim2 shape Standard deviation of coordinates along the second
principal axis
std dim3 shape Standard deviation of coordinates along the third
principal axis
rgyr shape Radius of gyration. Root mean square distance of atomic
coordinates from the center of mass
pmi shape Absolute value of the principal moment of inertia
pmiX shape x–component of the principal moment of inertia
pmiY shape y–component of the principal moment of inertia
pmiZ shape z–component of the principal moment of inertia
dipole charge Absolute value of the dipole moment
AM1 dipole charge AM1 dipole moment
PM3 dipole charge PM3 dipole moment
MNDO dipole charge MNDO dipole moment
dipoleX charge x–component of the dipole moment
dipoleY charge y–component of the dipole moment
dipoleZ charge z–component of the dipole moment
ASA surface Solvent-accessible surface area calculated using a probe of
radius 1.4 A˚
ASA+ surface Solvent-accessible surface area of positively charged atoms
ASA- surface Water accessible surface area of negatively charged atoms.
ASA H surface Solvent-accessible surface area of hydrophobic atoms
ASA P surface Solvent-accessible surface area of polar atoms
CASA+ surface Positively charged weighted surface area: ASA+
multiplied with the partial charge of the most positive
atom (Stanton and Jurs, 1990)
CASA- surface Negatively charged weighted surface area: ASA multiplied
with the partial charge of the most negative atom
(Stanton and Jurs, 1990)
DASA surface Absolute value of the difference between ASA+ and ASA
DCASA surface Absolute value of the difference between CASA+ and
CASA- (Stanton and Jurs, 1990)
FASA+ surface Fraction of the positively charged solvent-accessible
surface area: ASA+ divided by ASA
FASA- surface Fraction of the negatively charged solvent-accessible
surface area: ASA- divided by ASA
FASA H surface Fraction of the hydrophobic solvent-accessible surface
area: ASA divided by ASA
FASA P surface Fraction of the polar solvent-accessible surface area:
ASA P divided by ASA
FCASA+ surface Fractional positively charged weighted surface area:
CASA+ divided by ASA
FCASA- surface Fractional negatively charged weighted surface area:
CASA- divided by ASA
VSA surface Van der Waals surface area
dens volume Density. Molecular weight divided by the van der Waals
volume
vol volume van der Waals volume approximation
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Figure B.1: Simulated lead optimization trials with decision tree classification. Average
potencies (left) and compound numbers (right) over 500 calculations of 10 iterations
each are reported for training sets of five and 10 compounds. Decision tree classification
completely fails to produce highly potent compound sets because it is unable to handle
training sets containing only five compounds.
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Figure B.1: continued.
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Figure B.1: continued.
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Figure B.2: Simulated lead optimization trials with binary QSAR classification. Average
potencies (left) and compound numbers (right) over 500 calculations of 10 iterations
each are reported for training sets of five and 10 compounds. The ECP-based ex-
periments described in section 4.1 reach higher potency levels in few iterations. For
HIVPROT, binary QSAR completely fails to produce nano molar compound sets.
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Figure B.2: continued.
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Figure B.2: continued.

C Simulated Sequential Screening
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Figure C.1: Structures of all 32 DHFR inhibitors used in the simulated sequential screen-
ing experiment described in chapter 4.
95

D Patterns for Conformation Analysis
Emerging chemical patterns for the remaining 15 classes presented in section 3.1.
In all tables, “Growth” gives the growth rate of a pattern, “B” (“B%”) stands for
the absolute (relative) support in the binding conformation class, “M” (“M%”)
stands for the absolute (relative) support in the modeled conformation data set
and “Pattern” shows the pattern.
Table D.1: Discriminatory Patterns for Acetylcholine Esterase Inhibitors
Growth B [%] B M [%] M Pattern
∞ 100 5 0 0 {E strain:(9.79,∞]}
∞ 80 4 0 0 {E str:(20.31,∞]}
∞ 60 3 0 0 {E strain:(15.34,24.46]}
∞ 60 3 0 0 {E str:(14.90,∞], vol:(197.50,351.56]}
∞ 60 3 0 0 {E str:(14.90,∞], pmiY:(334.58,1141.06]}
∞ 60 3 0 0 {E str:(14.90,∞], VSA:(219.79,391.36]}
∞ 60 3 0 0 {E str:(14.90,∞],
PM3 Eele:(−755075.90,−335581.90]}
∞ 60 3 0 0 {E str:(14.90,∞],
MNDO Eele:(−788514.20,−336721.10]}
∞ 60 3 0 0 {E str:(14.90,∞], E vdw:(28.30,72.89]}
∞ 60 3 0 0 {E str:(14.90,∞], E tor:(−∞,1.88]}
∞ 60 3 0 0 {CASA+:(404.72,1956.91], E str:(14.90,∞]}
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Table D.2: Discriminatory Patterns for Carbonic anhydrase Inhibitors
Growth B [%] B M [%] M Pattern
∞ 100 21 0 0 {E strain:(12.92,∞]}
∞ 90 19 0 0 {E str:(6.05,∞]}
∞ 86 18 0 0 {E strain:(24.46,∞]}
∞ 86 18 0 0 {E stb:(−∞,−1.27]}
∞ 76 16 0 0 {E str:(14.90,∞]}
∞ 76 16 0 0 {E ang:(17.54,∞], dipole:(1.31,∞]}
∞ 71 15 0 0 {E ang:(24.53,∞]}
∞ 62 13 0 0 {E stb:(−∞,−2.63]}
∞ 62 13 0 0 {E:(48.58,∞]}
121.95 62 13 1 1 {E sol:(−20.79,−12.58], dipole:(1.31,∞]}
121.95 62 13 1 1 {E sol:(−20.79,−12.58], E vdw:(28.30,72.89]}
65.67 67 14 1 2 {E ang:(17.54,∞], E sol:(−20.79,−12.58]}
34.40 52 11 2 3 {E sol:(−20.79,−12.58], std dim2:(−∞,1.39]}
34.40 52 11 2 3 {E ang:(17.54,∞], std dim2:(−∞,1.39]}
Table D.3: Discriminatory Patterns for Carboxypeptidase Inhibitors
Growth B [%] B M [%] M Pattern
∞ 100 8 0 0 {E strain:(24.46,∞]}
∞ 100 8 0 0 {E str:(14.90,∞]}
∞ 100 8 0 0 {E strain:(28.68,∞]}
∞ 100 8 0 0 {E str:(13.71,∞]}
∞ 63 5 0 0 {E ang:(23.84,∞]}
∞ 50 4 0 0 {E:(128.36,∞]}
29.50 50 4 2 1 {E tor:(12.17,∞]}
18.44 63 5 3 2 {dipoleZ:(−∞,−1.24]}
14.75 50 4 3 2 {E ele:(−11.07,∞], E sol:(−∞,−177.16],
FASA P:(−∞,0.32]}
14.75 50 4 3 2 {E ele:(−11.07,∞], E sol:(−∞,−177.16],
FASA H:(0.68,∞]}
14.75 50 4 3 2 {E ele:(−11.07,∞], E nb:(42.27,136.00],
MNDO HF:(−∞,−79.25]}
14.75 50 4 3 2 {AM1 dipole:(8.17,17.34], E ele:(−11.07,∞],
rgyr:(2.97,5.32]}
12.29 63 5 5 3 {AM1 dipole:(8.17,17.34], E ele:(−11.07,∞],
FASA P:(−∞,0.32]}
11.06 75 6 7 4 {dipoleZ:(−∞,−1.01]}
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Table D.4: Discriminatory Patterns for Cyclin-dependent Kinase Inhibitors
Growth B [%] B M [%] M Pattern
∞ 100 31 0 0 {E strain:(24.46,∞]}
∞ 100 31 0 0 {E strain:(23.84,∞]}
∞ 100 31 0 0 {E str:(10.07,∞]}
∞ 90 28 0 0 {E str:(14.90,∞]}
∞ 52 16 0 0 {E:(118.44,∞]}
28.57 58 18 2 5 {E:(82.08,147.95], E nb:(−∞,42.27]}
10.38 55 17 5 13 {E:(82.08,147.95], VSA:(219.79,391.36]}
9.77 52 16 5 13 {E:(82.08,147.95], vol:(197.50,351.56]}
9.07 52 16 6 14 {E:(82.08,147.95], PM3 dipole:(−∞,9.76]}
9.07 52 16 6 14 {E:(82.08,147.95], MNDO dipole:(−∞,8.98]}
9.07 52 16 6 14 {AM1 IP:(5.51,10.61], E:(82.08,147.95],
pmi:(2429.75,10083.21]}
9.07 52 16 6 14 {AM1 HOMO:(−10.61,−5.51], E:(82.08,147.95],
pmi:(2429.75,10083.21]}
Table D.5: Discriminatory Patterns for Elastase Inhibitors
Growth B [%] B M [%] M Pattern
∞ 100 3 0 0 {FASA-:(0.47,∞], pmiY:(1141.06,∞],
std dim1:(3.33,∞], std dim3:(1.21,∞]}
∞ 100 3 0 0 {FASA-:(0.47,∞], pmiY:(1141.06,∞],
pmiZ:(538.74,∞], std dim1:(3.33,∞]}
∞ 100 3 0 0 {FASA-:(0.47,∞], glob:(0.10,∞], pmiY:(1141.06,∞],
std dim1:(3.33,∞]}
∞ 100 3 0 0 {FASA-:(0.47,∞], PM3 HF:(−∞,−197.90],
std dim1:(3.33,∞], std dim3:(1.21,∞]}
∞ 100 3 0 0 {FASA-:(0.47,∞], PM3 HF:(−∞,−197.90],
pmiZ:(538.74,∞], std dim1:(3.33,∞]}
∞ 100 3 0 0 {FASA-:(0.47,∞], PM3 HF:(−∞,−197.90],
glob:(0.10,∞], std dim1:(3.33,∞]}
∞ 100 3 0 0 {E strain:(24.46,∞]}
∞ 100 3 0 0 {E ele:(−11.07,∞], FASA-:(0.47,∞],
std dim1:(3.33,∞], std dim3:(1.21,∞]}
∞ 100 3 0 0 {E ele:(−11.07,∞], FASA-:(0.47,∞],
pmiZ:(538.74,∞], std dim1:(3.33,∞]}
∞ 100 3 0 0 {E strain:(16.91,∞]}
∞ 100 3 0 0 {E str:(8.96,∞]}
∞ 100 3 0 0 {E:(85.27,∞]}
∞ 67 2 0 0 {E ele:(1.88,∞]}
∞ 67 2 0 0 {E ang:(22.32,∞]}
29.00 100 3 3 1 {PM3 dipole:(−∞,4.26]}
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Table D.6: Discriminatory Patterns for Endothiapepsin Inhibitors
Growth B [%] B M [%] M Pattern
∞ 100 6 0 0 {E strain:(24.46,∞]}
∞ 100 6 0 0 {E str:(14.90,∞]}
∞ 100 6 0 0 {glob:(−∞,0.10]}
∞ 100 6 0 0 {E strain:(43.04,∞]}
∞ 83 5 0 0 {E str:(19.79,∞]}
∞ 83 5 0 0 {E stb:(−∞,−0.14]}
∞ 83 5 0 0 {E ang:(29.37,∞]}
∞ 83 5 0 0 {E:(116.41,∞]}
∞ 67 4 0 0 {glob:(0.01,0.08]}
∞ 67 4 0 0 {E tor:(1.88,∞], dipole:(1.31,∞]}
∞ 67 4 0 0 {E nb:(42.27,136.00], E tor:(1.88,∞]}
∞ 67 4 0 0 {E:(147.95,∞]}
∞ 67 4 0 0 {std dim1:(5.15,∞]}
∞ 67 4 0 0 {rgyr:(5.78,∞]}
∞ 67 4 0 0 {E nb:(68.19,∞]}
∞ 67 4 0 0 {AM1 dipole:(11.85,∞]}
∞ 50 3 0 0 {dipoleX:(−∞,−1.59]}
∞ 50 3 0 0 {PM3 IP:(−∞,5.59]}
∞ 50 3 0 0 {PM3 HOMO:(−5.59,∞]}
∞ 50 3 0 0 {pmi:(23385.78,∞]}
15.00 83 5 6 1 {std dim3:(−∞,1.38]}
15.00 83 5 6 1 {pmiZ:(−∞,1011.65]}
15.00 83 5 6 1 {pmiX:(13024.76,∞]}
Table D.7: Discriminatory Patterns for Factor Xa Inhibitors
Growth B [%] B M [%] M Pattern
∞ 100 10 0 0 {E strain:(24.46,∞]}
∞ 100 10 0 0 {E str:(14.90,∞]}
∞ 100 10 0 0 {E strain:(17.83,∞]}
∞ 100 10 0 0 {E str:(12.19,∞]}
∞ 60 6 0 0 {CASA+:(1956.91,∞], E ang:(17.54,∞],
pmi:(10083.21,∞]}
∞ 50 5 0 0 {CASA+:(1956.91,∞], FCASA-:(1.40,3.21],
pmi:(10083.21,∞]}
72.00 80 8 1 1 {E ang:(23.79,∞]}
54.00 60 6 1 1 {E oop:(−∞,0.02]}
18.00 60 6 3 3 {ASA+:(426.07,∞], E ang:(17.54,∞],
pmi:(10083.21,∞]}
15.00 50 5 3 3 {E:(82.08,147.95], std dim3:(1.21,∞]}
15.00 50 5 3 3 {ASA+:(426.07,∞], FCASA-:(1.40,3.21],
pmi:(10083.21,∞]}
15.00 50 5 3 3 {ASA+:(426.07,∞], CASA-:(1025.33,1591.69]}
15.00 50 5 3 3 {ASA:(653.76,791.58], E ang:(17.54,∞],
PM3 E:(−124393.40,−95187.02]}
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Table D.8: Discriminatory Patterns for FK506 Binding Protein Inhibitors
Growth B [%] B M [%] M Pattern
∞ 100 6 0 0 {E strain:(3.82,∞]}
∞ 67 4 0 0 {E strain:(24.46,∞]}
∞ 67 4 0 0 {ASA H:(468.24,665.84], E ang:(17.54,∞]}
∞ 50 3 0 0 {E ang:(17.54,∞], vol:(351.56,486.00]}
∞ 50 3 0 0 {E ang:(17.54,∞], pmi:(2429.75,10083.21]}
∞ 50 3 0 0 {E ang:(17.54,∞], VSA:(391.36,553.94]}
∞ 50 3 0 0 {E ang:(17.54,∞],
PM3 Eele:(−1429154.00,−755075.90]}
∞ 50 3 0 0 {E ang:(17.54,∞], PM3 E:(−124393.40,−95187.02]}
∞ 50 3 0 0 {E ang:(17.54,∞],
MNDO Eele:(−1515367.00,−788514.20]}
∞ 50 3 0 0 {E ang:(17.54,∞],
MNDO E:(−158562.00,−105111.10]}
∞ 50 3 0 0 {E str:(11.74,∞]}
Table D.9: Discriminatory Patterns for HIV Protease Inhibitors
Growth B [%] B M [%] M Pattern
∞ 100 20 0 0 {E strain:(24.46,∞]}
∞ 100 20 0 0 {E strain:(21.68,∞]}
∞ 65 13 0 0 {E str:(16.49,∞]}
45.83 65 13 1 2 {E stb:(−∞,−0.12]}
32.90 70 14 2 3 {E:(147.95,∞]}
14.10 70 14 5 7 {E str:(14.90,∞]}
10.97 70 14 6 9 {glob:(−∞,0.12]}
5.88 50 10 9 12 {ASA:(791.58,∞], ASA H:(665.84,∞],
ASA P:(−∞,210.39], E ang:(17.54,∞],
E tor:(1.88,∞], PM3 LUMO:(−0.74,0.54]}
5.54 55 11 10 14 {ASA H:(665.84,∞], E ang:(17.54,∞],
E ele:(−11.07,∞], FCASA+:(1.78,∞],
std dim1:(3.33,∞]}
5.54 55 11 10 14 {ASA H:(665.84,∞], E ang:(17.54,∞],
E ele:(−11.07,∞], FASA+:(0.54,∞],
std dim1:(3.33,∞]}
5.54 55 11 10 14 {ASA H:(665.84,∞], E ang:(17.54,∞],
E ele:(−11.07,∞], E tor:(1.88,∞],
std dim1:(3.33,∞]}
5.54 55 11 10 14 {ASA H:(665.84,∞], E ang:(17.54,∞],
E ele:(−11.07,∞], E tor:(1.88,∞],
FCASA+:(1.78,∞]}
5.54 55 11 10 14 {ASA H:(665.84,∞], E ang:(17.54,∞],
E ele:(−11.07,∞], E tor:(1.88,∞],
FASA+:(0.54,∞]}
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Table D.10: Discriminatory Patterns for Plasminogen Activator Inhibitors
Growth B [%] B M [%] M Pattern
∞ 100 7 0 0 {E strain:(10.78,∞]}
∞ 86 6 0 0 {E strain:(24.46,∞]}
∞ 71 5 0 0 {E str:(14.90,∞]}
∞ 71 5 0 0 {E str:(11.78,∞]}
∞ 71 5 0 0 {E stb:(0.77,∞]}
∞ 71 5 0 0 {E:(92.13,∞]}
12.00 57 4 5 2 {E ang:(17.54,∞]}
14.00 100 7 7 3 {E ang:(12.42,∞]}
6.00 57 4 10 4 {dipoleX:(−∞,−1.59], std dim1:(2.41,3.33]}
6.00 57 4 10 4 {E ele:(−11.07,∞], std dim1:(2.41,3.33]}
6.00 57 4 10 4 {E ele:(−11.07,∞], PM3 IP:(10.77,∞],
dipoleX:(−∞,−1.59]}
6.00 57 4 10 4 {E ele:(−11.07,∞], PM3 IP:(10.77,∞],
PM3 dipole:(9.76,∞]}
6.00 57 4 10 4 {E ele:(−11.07,∞], PM3 HOMO:(−∞,−10.77],
dipoleX:(−∞,−1.59]}
6.00 57 4 10 4 {E ele:(−11.07,∞], PM3 HOMO:(−∞,−10.77],
PM3 dipole:(9.76,∞]}
Table D.11: Discriminatory Patterns for Protein Tyrosine Phosphatase 1b Inhibitors
Growth B [%] B M [%] M Pattern
∞ 100 14 0 0 {E strain:(24.46,∞]}
∞ 100 14 0 0 {E strain:(26.79,∞]}
∞ 93 13 0 0 {E str:(14.90,∞]}
∞ 93 13 0 0 {E str:(16.03,∞]}
∞ 57 8 0 0 {ASA P:(210.39,282.26], E ele:(−11.07,∞],
E tor:(1.88,∞]}
37.71 57 8 2 1 {AM1 IP:(−∞,5.51], ASA P:(210.39,282.26],
E tor:(1.88,∞]}
37.71 57 8 2 1 {AM1 HOMO:(−5.51,∞], ASA P:(210.39,282.26],
E tor:(1.88,∞]}
33.00 50 7 2 1 {E ang:(17.54,∞], dipoleX:(−∞,−1.59]}
33.00 50 7 2 1 {ASA P:(210.39,282.26], E ang:(17.54,∞]}
25.93 79 11 3 2 {E ang:(21.00,∞]}
21.21 64 9 3 2 {E ele:(−11.07,∞], E tor:(1.88,∞],
dipoleX:(−∞,−1.59]}
16.50 50 7 3 2 {E ang:(17.54,∞], FCASA-:(1.40,3.21]}
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Table D.12: Discriminatory Patterns for Protocatechuate3,4-dioxygenase Inhibitors
Growth B [%] B M [%] M Pattern
∞ 100 10 0 0 {E strain:(2.55,∞]}
∞ 90 9 0 0 {E str:(2.76,∞]}
∞ 80 8 0 0 {E strain:(4.30,15.34]}
∞ 70 7 0 0 {pmiZ:(0.01,1.43]}
∞ 60 6 0 0 {std dim3:(0.01,0.05]}
∞ 60 6 0 0 {glob:(0.00,0.00]}
∞ 60 6 0 0 {E tor:(1.55,∞]}
∞ 60 6 0 0 {E oop:(0.09,∞]}
13.50 90 9 7 1 {E ang:(2.73,∞], pmiY:(−∞,201.06]}
12.00 80 8 7 1 {E:(25.00,∞], pmiY:(−∞,201.06]}
Table D.13: Discriminatory Patterns for Thermolysin Inhibitors
Growth B [%] B M [%] M Pattern
∞ 100 6 0 0 {E strain:(24.46,∞]}
∞ 100 6 0 0 {E str:(14.90,∞]}
∞ 100 6 0 0 {E strain:(42.00,∞]}
∞ 100 6 0 0 {E str:(16.05,∞]}
∞ 100 6 0 0 {E:(99.01,∞]}
∞ 83 5 0 0 {E ele:(−11.07,∞], E nb:(42.27,136.00]}
∞ 83 5 0 0 {E stb:(−∞,−0.45]}
∞ 83 5 0 0 {E ele:(−3.67,∞]}
∞ 50 3 0 0 {E ang:(17.54,∞], dipoleX:(−∞,−1.59]}
∞ 50 3 0 0 {E:(147.95,∞]}
∞ 50 3 0 0 {CASA-:(1025.33,1591.69], E ele:(−11.07,∞]}
∞ 50 3 0 0 {ASA-:(275.40,∞], PM3 HF:(−197.90,−85.25],
PM3 dipole:(9.76,∞]}
41.00 100 6 2 1 {E nb:(42.27,136.00], PM3 dipole:(9.76,∞]}
34.17 83 5 2 1 {E ang:(17.54,∞], E ele:(−11.07,∞]}
20.50 100 6 5 2 {E nb:(46.18,∞]}
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Table D.14: Discriminatory Patterns for Thrombin Inhibitors
Growth B [%] B M [%] M Pattern
∞ 100 21 0 0 {E strain:(16.48,∞]}
∞ 95 20 0 0 {E strain:(24.46,∞]}
∞ 95 20 0 0 {E str:(9.67,∞]}
∞ 62 13 0 0 {E str:(14.90,∞]}
∞ 62 13 0 0 {E:(124.47,∞]}
∞ 52 11 0 0 {E:(147.95,∞]}
44.86 57 12 1 2 {E oop:(0.97,∞]}
5.87 52 11 9 14 {E nb:(42.27,136.00], E tor:(1.88,∞],
pmi:(2429.75,10083.21], std dim1:(3.33,∞]}
5.14 52 11 10 16 {E nb:(42.27,136.00], std dim1:(3.33,∞],
std dim2:(1.81,∞], vol:(351.56,486.00]}
5.14 52 11 10 16 {E nb:(42.27,136.00], pmiY:(1141.06,∞],
std dim1:(3.33,∞], vol:(351.56,486.00]}
5.14 52 11 10 16 {E nb:(42.27,136.00], VSA:(391.36,553.94],
dens:(−∞,1.24], glob:(0.10,∞], pmiY:(1141.06,∞],
std dim1:(3.33,∞]}
5.14 52 11 10 16 {ASA H:(468.24,665.84], E nb:(42.27,136.00],
std dim1:(3.33,∞], std dim2:(1.81,∞]}
5.14 52 11 10 16 {ASA H:(468.24,665.84], E nb:(42.27,136.00],
pmiY:(1141.06,∞], std dim1:(3.33,∞]}
Table D.15: Discriminatory Patterns for Tyrosine Kinase Inhibitors
Growth B [%] B M [%] M Pattern
∞ 100 5 0 0 {E strain:(24.46,∞]}
∞ 100 5 0 0 {E strain:(32.80,∞]}
∞ 80 4 0 0 {E str:(12.68,∞]}
∞ 60 3 0 0 {E str:(14.90,∞]}
∞ 60 3 0 0 {E:(82.08,147.95], E vdw:(28.30,72.89],
FASA P:(0.32,0.52],
MNDO Eele:(−∞,−1515367.00]}
∞ 60 3 0 0 {E:(82.08,147.95], E vdw:(28.30,72.89],
FASA H:(0.48,0.68],
MNDO Eele:(−∞,−1515367.00]}
∞ 60 3 0 0 {dipoleZ:(−∞,−1.91]}
∞ 60 3 0 0 {MNDO IP:(0.17,∞]}
∞ 60 3 0 0 {MNDO HOMO:(−∞,−0.17]}
17.60 80 4 5 1 {E nb:(42.27,136.00], FASA P:(0.32,0.52]}
17.60 80 4 5 1 {E nb:(42.27,136.00], FASA H:(0.48,0.68]}
17.60 80 4 5 1 {ASA P:(282.26,∞], E nb:(42.27,136.00]}
17.60 80 4 5 1 {ASA H:(468.24,665.84], E nb:(42.27,136.00]}
17.60 80 4 5 1 {PM3 IP:(−0.45,∞]}
17.60 80 4 5 1 {PM3 HOMO:(−∞,0.45]}
13.20 60 3 5 1 {E vdw:(28.30,72.89], FASA P:(0.32,0.52],
dipoleX:(−1.59,∞], rgyr:(5.32,∞]}
11.00 100 5 9 2 {E ele:(−18.26,∞]}
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Eidesstattliche Erkla¨rung
An Eides statt versichere ich hiermit, dass ich die Dissertation ”Emerging Che-
mical Patterns for Virtual Screening and Knowledge Discovery“ selbst und ohne
jede unerlaubte Hilfe angefertigt habe, dass diese oder eine a¨hnliche Arbeit noch
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